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ABSTRACT OF THE DISSERTATION
Molecular and Epigenetic Regulation of Stem Cell Radiosensitivity
by
Keith Michael Jacobs
Doctor of Philosophy in Biology and Biomedical Sciences
Molecular Cell Biology
Washington University in St. Louis, 2015
Professor Dennis Hallahan, Chair

Normal tissue injury resulting from ionizing radiation (IR) during cancer radiotherapy has been attributed
to reduced regenerative capacity of stem cell compartments. Utilizing multiple in vivo tissue niches and
primary culture models, we demonstrate that normal stem cells are highly radiosensitive while their
isogenic, directly differentiated progeny are radioresistant. Stem cell dropout is therefore likely
responsible for the resulting radiation injury in these niches. This differential radiosensitivity is
independent of proliferation status, and increased IR-induced apoptosis in stem cells is more broadly
distributed across the cell cycle.
We elucidate that stem cells exhibit an attenuated DDR resulting in aberrant cell cycle checkpoint
activation and severely diminished DNA repair capacity despite normal sensing of DNA double strand
breaks. Interestingly, while these stem cells are unable to induce γH2AX foci, apoptosis induces pannuclear H2AX S139 phosphorylation together with activation of MST1 and JNK. This apoptotic signaling
corresponds to a unique inability of stem cells to dephosphorylate H2AX-Y142 around break sites, which
promotes apoptosis through JNK while inhibiting DDR signaling. By investigating these molecular
responses for the first time in stem cells, we provide potential mechanisms for IR-induced apoptosis
independent of DDR signaling. The abrogated DDR in stem cells is also associated with constitutively
elevated histone-3 lysine-56 acetylation, which contributes to IR-induced apoptosis through restriction of
the DDR and can be modulated to impart radioprotection on stem cells.

x

This data establishes that unique epigenetic landscapes among differing cell types can impart
heterogeneity in the DDR, resulting in varying radiosensitivities and challenging prior assumptions about
the ubiquitous nature of canonical DDR signaling. We thus identify pluralistic molecular and epigenetic
mechanisms that collectively contribute to IR hypersensitivity in stem cells, promoting development of
future therapeutic strategies for minimizing deleterious sequelae from radiotherapy.
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CHAPTER 1
Introduction

1

1.1 RADIATION THERAPY
Radiation therapy is commonly used to destroy localized tumors in cancer patients. Radiation therapy
utilizes ionizing radiation (IR) to kill cancer cells through the induction of damaging DNA double-strand
breaks (DSBs). DSBs are more detrimental than single strand breaks because DSBs do not have an
undamaged strand available to use as a repair template. DSBs may ultimately lead to chromosomal
1

aberrations which severely impinge on genomic integrity . Unfortunately, tumors often evolve resistance
2,3

to DNA damage-induced cell death through inactivation of apoptosis pathways . Additionally, cancer
stem cells within many tumors are believed to be especially radioresistant

4,5

and can inhibit complete

6

eradication of the tumor . The relative radioresistance of cancer cells requires the use of increased and
8

repeated IR doses, which often result in injury to normal tissue .

1.1.1 Physics of Ionizing Radiation
Ionizing radiation is defined as radiation that imparts enough energy to cause ejection of one or
8

more electrons from its target atoms, resulting in the localized release of energy . The energy
released per displaced electron is approximately 33eV, which is enough energy to break chemical
bonds of nearby molecules. Ionizing radiation can be classified as either electromagnetic or
particulate. IR induces DSBs both directly through the energy imparted from the radiation as well
as indirectly by the creation of highly reactive hydroxyl radicals (reactive oxygen species or ROS)
8,9

from nearby water or other molecules . Only particulate radiation typically imparts enough energy
to directly induce DNA breaks, while all forms of radiation can induce indirect ionization. X-rays
and γ-rays are electromagnetic radiation, while atomic particles and heavy ions represent
particulate radiation. X-rays are created by focusing the kinetic energy produced from accelerated
electrons, while gamma rays emanate through natural decay of radioactive isotopes. Atomic
particle radiation includes electrons, protons, alpha particles and neutrons, all of which can be
used for radiation therapy. Heavy ions include the nuclei of carbon, neon, argon, or iron that have
had electrons removed to create a positive charge and can be used for radiation therapy with
specialized accelerators. Heavy ions are also present in outer space and are a major potential
8

danger for astronauts during long space voyages . Ionizing radiation is typically measured as
2

absorbed dose in the unit of grays (Gy), which equals 100 rad or 1 Joule of deposited energy per
10

kilogram of tissue . There are also measures of effective dose, to account for differing biological
effects of various forms of radiation relative to their respective linear energy transfer (LET), or the
average amount of energy deposited per linear unit of length. X-rays, electrons, gamma rays and
protons exhibit a significantly lower LET than neutrons, alpha particles and heavy ions and
8

therefore have a less efficient biological effect per dose . The sievert (Sv), which equals 100 rem,
11

is the international unit for effective dose, and a Gray is similar to a Sievert for low LET radiation .

1.1.2 Cancer Radioresistance
While radiation therapy is an often effective treatment for destroying cancer, inactivation of the
2,3

apoptotic factor p53 and other evolutionary mutations impart radioresistance upon cancer cells .
Inactivation of DNA repair factors and the DNA Damage Response (discussed below) is often an
important step in cellular transformation by promoting genomic instability and preventing the
12

induction of programmed cell death . While mutation of repair factors can indeed sensitize cancer
cells, associated inhibition of apoptosis can promote resistance and further mutational evolution.
Because of the common loss-of-function of apoptosis in cancer cells, cell death often involves
other mechanisms. Cancer cells often die through mitotic catastrophe, whereby residual
unrepaired DNA damage results in severe chromosomal defects following mis-segregation during
mitosis, leading to delayed p53-independent apoptosis. Additionally, DNA damage may induce
senescence in cancer, which does not destroy cells but stops their division and therefore can halt
the proliferation of a tumor

3,13

.

While their existence is still debated, cancer stem cells are believed to be extremely radioresistant,
thereby contributing to the overall radioresistance of tumors and promoting cancer recurrence

6,14

Cancer stem cells exhibit resistance in part through elevated DNA Damage Response signaling,
increased aldehyde dehydrogenase and ABC transporter activity (which are less important for
radiation but can inactivate or remove chemotherapeutic drugs), a hypoxic microenvironment,
increased free-radical scavengers, activation of self-renewal pathways and even potentially
3

.

reduced proliferation

4–6,14–16

. Unique strategies to target these mechanisms may be required in

conjunction with radiation treatment in order to sufficiently destroy cancer stem cells.

1.1.3 Whole Body Irradiation Dosage and Mortality
In addition to the relative radioresistance of tumors, the effectiveness of radiation therapy is also
limited by clinical side effects on normal tissue. Acute clinical consequences of accidental wholebody radiation exposure such as from nuclear disasters are dosage-dependent. Doses below 2Gy
are considered subclinical and may only result in a temporary drop in blood cell counts along with
some mild nausea or headache. Hematopoietic injury and white blood cell loss occurs at doses of
2Gy and above, which can lead to death within 30 days from bone marrow depletion due to
10

infection or hemorrhaging . During this hematopoietic syndrome, rapid depletion of lymphocytes
is followed by gradual reduction in granulocytes, platelets and red blood cells, leading to impaired
immunity, poor wound healing and excessive bleeding. Exposure to single doses of 10Gy and
above produce gastrointestinal damage and potential death within 2-3 weeks from organ failure,
sepsis and internal bleeding, with symptoms including loss of nutrient absorption, severe nausea
and vomiting, diarrhea, anorexia and abdominal pain. More global effects can be observed above
10Gy, with patients experiencing “fatigue syndrome” consisting of central nervous system
manifestations such as fever, headache, disorientation, reduced reflexes, diminished coordination
and even occasional loss of consciousness. Exposure to more than 30Gy induces cardiovascular
and central nervous system failure resulting in death within a few days due to loss of blood vessel
integrity and brain swelling/inflammation. All of these doses also induce nausea and vomiting
11

within the first 12 hours following exposure .

1.1.3.1 Linear No-Threshold Hypothesis
Exposure to doses below 1Gy does not result in any significant risk of tissue injury,
although continued exposure does increase cancer risk in a dose-dependent
manner

11,17,18

. The linear no-threshold (LNT) hypothesis proposes that any and all doses

of radiation pose some cancer risk, and therefore no “safe” levels of radiation exist
4

17,18

.

This hypothesis is faulty however, and acute doses below 100mSv or continued exposure
below 500mSv fails to promote any increased cancer risk. In contrast, strong evidence
exists for beneficial effects of exposure to very low levels of radiation, known as hormesis.
Radiation hormesis develops within hours of exposure and its effects can last up to
months, including reduction of reactive oxygen species, death of previously damaged
cells, immune stimulation, and modification of cell cycle parameters including senescence.
These adaptive mechanisms all combine to protect long term genomic integrity and
reduce the risk of future carcinogenesis

17,19

.

1.1.4 Chronic and late effects of radiation injury
Consequences of localized normal tissue injury include both acute and chronic sequelae such as
20

hematopoietic dysfunction , cognitive impairment

21,22

23

, infertility , intestinal epithelial erosion

24,25

26

and hair loss . These pathologies result from deficient tissue regeneration following normal cell
turnover and thus have been attributed to the depletion of regenerative stem cell
compartments

7,27,28

. The timing of the clinical onset of these symptoms is therefore dictated by the

turnover rate of the affected tissue, with early consequences presenting only days or weeks
7

following irradiation in rapidly dividing tissues and late-onset effects in slow-dividing tissues .

Many chronic symptoms only present months to years following radiation damage and are not
related to stem cell loss or tissue proliferation rate. The processes involved in this type of injury
include fibrosis, necrosis, inflammation, atrophy, and vascular damage

7,29

. These mechanisms all

interact in creating long-term damage. Fibrosis is excessive scarring due to overactive wound
30

healing and is probably the most common type of injury following radiation damage , appearing
often among stromal cells of many tissues. Tissue necrosis and atrophy result in degeneration of
the affected tissue. Necrosis is most damaging to the cerebral white matter of the brain while
atrophy is characterized by sequential destruction of epithelial tissue. Endothelial cell damage and
immunological inflammation lead to reduced vascular integrity, causing further broad tissue

5

damage through ischemia. Inflammatory responses can promote many of the above mechanisms
as well as tissue-specific forms of radiation injury such as pneumonitis in lung

7,31,32

.

1.1.4.1 Radiation Dose Fractionation
The requirement to balance tumor elimination while minimizing side effects limits the
overall effectiveness of radiation therapy, so identifying methods for improved
radioprotection of normal tissue is indispensible for improving the efficacy of cancer
7

treatment . One treatment method that has been developed to maximize efficiency of cell
killing on cancer cells while sparing normal tissue is dose fractionation. Dose fractionation
attempts to take advantage of the differences in cell cycle kinetics and tissue
microenvironment between tumor and normal tissue in order to bias cell killing toward
cancer cells while sparing normal tissue. The effect of fractionation is based on the four
“R” factors of radiobiology: repair of sublethal damage, cell cycle reassortment,
reoxygenation, and repopulation. Fractionation increases the effectiveness of radiation on
destroying tumors because it allows reoxygenation of previously hypoxic cancer cells and
promotes reassortment of cycling cells into more radiosensitive phases of the cell cycle.
Hypoxic cells are resistant to ROS-mediated DNA damage, so repeated irradiation of
tumors sensitizes previously hypoxic cancer cells once the aerated surrounding cells have
33

died . At the same time, fractionation spares normal tissue by allowing time for DNA
repair and progenitor repopulation of damaged regions. The dose, number and time delay
of fractions must be calculated to maximize these benefits for each tissue type based on
relative proliferation rate. These factors must all be carefully determined when attempting
to balance the sparing of fast-dividing normal tissues with effective killing of an entire
34

tumor cell population .

1.1.5 Radiosensitivity and Proliferation
Radiosensitivity differs greatly among tissues and cell types, and the cellular variables underlying
differences in radiosensitivity have been studied for over a century. Two major determinants of
6

radiosensitivity include proliferation rate and cell cycle status. Bergonié and Tribondeau in 1906
compared the radiosensitivity of various tissues and concluded that there was a direct correlation
35

between proliferation rate and radiosensitivity for both normal and cancerous tissue . This has
since become a central tenet of radiobiology and continues to influence the interpretation of
clinical outcomes from radiotherapy. As might be expected however, the “Law of Bergonié and
36

Tribondeau” is an oversimplification that has numerous counterexamples . Most notably, this
tenet predicts that cancer cells should be inherently more radiosensitive than normal tissue due to
their enhanced proliferation rate, however cancer is often relatively radioresistant

2,3

. More

accurately, highly proliferative cells appear to exhibit merely a faster response to radiation

36,37

,

meaning that cell death will be observed earlier than in slower-dividing cells although not
necessarily more extensively.

1.1.6 Radiosensitivity and Cell Cycle Kinetics
Radiosensitivity also varies across the cell cycle. While there is certainly variability among cell
37

types , cells are typically most radiosensitive during G2/M phase, and especially during mitosis

38–

40

. Radiosensitivity is decreased during G1 phase and is minimal during the end of S phase.

Differential radiosensitivity throughout the cell cycle has historically been performed by irradiating
cells following synchronization by various cell cycle inhibitors, and some variability is also inherent
based on the particular method used to achieve synchronization. Live-sorting cells by flow
cytometry to avoid the use of inhibitors has also demonstrated similar hypersensitivity of G2/M
41

cells to low-dose IR .

1.2 MECHANISMS OF CELL DEATH
There are many forms of cell death, each activated in response to particular conditions and stimuli within
either the internal or external cellular environment. Major mechanisms of cell death likely to result from
radiation exposure are apoptosis, necrosis, mitotic catastrophe and autophagy. There are also additional
specialized forms of cell death unrelated to radiation damage such as anoikis (due to the loss of adhesive
interactions with the extracellular matrix), entosis (non-phagocytic engulfment of one cell by another) and
7

cornification (formation of the outer epidermal layer of dead keratinocytes as part of normal skin
42

development) . In addition to cell death, DNA damage and other stressors can also lead to replicative
43

arrest or senescence .

1.2.1 Necrosis
Necrosis has historically been believed to be a passive cell death mechanism in response to
tremendous external stress, resulting from conditions such as microbial toxins, immune
activation, certain types of DNA damage, inadequate signaling ligand availability and insufficient
nutrient access. However, more recently it has been established that necrosis can also be a form
of programmed cell death that is molecularly regulated as part of development and other normal
physiological processes, often sharing signaling pathways with apoptosis. Unlike apoptosis
however, the completion of necrosis results in cellular lysis, releasing cellular contents. If
necrosis occurs in response to infection, necrosis can thereby amplify infection by releasing
microbes and toxins into the environment. The release of cellular contents also induces an
immune response which can potentially accentuate tissue damage

42,44

.

1.2.2 Autophagy
Autophagy is a cytoprotective response whereby stressed or dying cells isolate and degrade
internal organelles in an attempt to preserve and recycle limited remaining resources. Inducers of
autophagy include starvation, absence of necessary growth factors and toxic agents. While
autophagy is considered a mechanism of cell death, except in the case of recycling cellular
resources or stimulating immune activation in dying cells, it is typically an emergency protective
mechanism. Autophagy attempts to maintain cellular homeostasis and energy reserves in order
to prevent cell death. Autophagy therefore primarily accompanies cell death as opposed to
regulating it, and inhibition of autophagy is often ineffective at preventing cell death induction

8

42,45

.

1.2.3 Mitotic Catastrophe
Mitotic catastrophe is cell death stimulated by major errors during mitosis, inducing destruction of
the cell either during mitosis or the subsequent G1 phase in order to prevent the propagation of
damaging chromosomal aberrations to future generations. Mitotic catastrophe can be identified
by the presence of small micronuclei or multiple nuclei. Mitotic catastrophe activates mitotic cell
cycle arrest through the DNA Damage Response and results in either cell death through
apoptosis/ necrosis or cell cycle exit as senescence. Mitotic catastrophe is not a true
independent mechanism of cell death but instead merely a checkpoint response that leads to cell
42

death through one of the previously described mechanisms .

1.2.4 Senescence
Senescence is sometimes considered to be a form of cell death, however despite not being able
to further proliferate, senescent cells are otherwise functional and metabolically active.
Senescence is most commonly enacted as “replicative senescence” due to the repeated
shrinking of telomeres below a certain threshold over several generations of cell division.
Shortening of telomeres activates the DNA Damage Response along with the cell cycle inhibitor
tumor suppressors p53, retinoblastoma protein (Rb) and p16, leading to permanent inactivation of
replicative capacity. Senescence can also be prematurely induced by multiple kinds of stress,
including exogenous DNA damage. It is considered to be a mechanism of tumor suppression
because in addition to maintaining genomic integrity in future generations, senescence is actually
43

induced in primary cells by the activation of oncogenes . Due to the inactivation of apoptosis in
many cancers

3,13

, senescence is often the dominant mechanism for tumor suppression by DNA

damaging agents. Senescent cells can be easily identified by their large, flat multinucleated
43

morphology along with expression of senescence-associated β-galactosidase .

1.2.5 Apoptosis
Apoptosis describes programmed cell death or “cellular suicide” through defined molecular
signaling pathways. Apoptosis can be enacted through either extrinsic or intrinsic mechanisms.
9

Extrinsic apoptosis induced programmed cell death through TNF family receptor-mediated
signaling based on either the presence of toxic ligands or reduced concentration of necessary
ligands. Signal transduction leads to activation of the initiator caspases 8,9, or 10, which then
activate the “executioner” caspases 3, 6 and 7. Extrinsic apoptosis is caspase-dependent but
does not always require mitochondrial permeabolization, which is an essential feature of the
intrinsic pathway. Multiple internal cellular stresses are capable of activating the intrinsic pathway,
including oxidative stress, DNA damage, accumulation of unfolded proteins, absence of growth
factors, and others. The intrinsic apoptosis pathway is regulated by a homeostatic balance of pro
and anti-apoptotic proteins. The Bcl-2 family of proteins include anti-apoptotic proteins such as
Bcl-2, Bcl-x and Bcl-xL, along with pro-apoptotic proteins such as Bax, Bad, Bid and Bim.
Apoptotic stimuli upregulate the relative amount of pro-apoptotic Bcl-2 family proteins,
overcoming their inhibition by anti-apoptotic family members and leading to mitochrondrial
permeabolization. Cytochrome c release from the permeabolized mitochondria induces formation
of the apoptosome complex, activating caspase-9 which subsequently activates caspases 3, 6
and 7. Caspase-3 is the primary executioner caspase and activates several downstream
substrates through cleavage, including caspase-activated DNase (CAD), which degrades nuclear
DNA and promotes chromosomal condensation. Caspase-3 also induces cytoskeletal changes
and disintegration of the cell as a whole. Caspase-independent apoptosis also occurs through
46

proteins such as apoptosis inducing factor (AIF) , which can directly induce DNA fragmentation
and chromatin condensation

42,47

. Unlike necrosis, degraded cellular contents remain packaged

within membranes during apoptosis, avoiding widespread immune activation and allowing
phagocytic disposal of dead cells by macrophages

44,47

.

1.2.5.1 p53 in Apoptosis
p53 is the major transcriptional regulator of apoptosis, upregulating the expression of proapoptotic Bcl-2 family members leading to mitochondrial permeabolization. p53 also
transcriptionally activates several other genes that promote apoptosis, including
phosphatase and tensin homolog (PTEN), an inhibitor of the pro-survival PI3 kinase
10

48

signaling pathway . The action of p53 is controlled by numerous DNA damage-induced
post-translational modifications which regulate its interaction with various substrates. p53
protein is maintained at low levels under basal conditions due to constitutive ubiquination
by Mouse double minute 2 homolog (MDM2). The DNA Damage Response factors
Ataxia telangiectasia mutated (ATM) and checkpoint kinase (Chk)1/2 phosphorylate p53
on serine 15 and 20, stabilizing the protein by blocking MDM2-mediated ubiquination.
Serine 46 is also phosphorylated, leading to induction of specific apoptotic genes,
although the responsible kinase is not known. p53 acetylation at multiple residues also
49

promotes DNA binding and subsequent transcriptional activation of apoptotic genes .

1.2.5.2 MST1-JNK-H2AX Pathway
Several overlapping pathways are involved in DNA fragmentation and chromatin
condensation at the end stages of apoptosis downstream of caspase-3 activation. One
important downstream target of caspase-3 is mammalian Ste20-like kinase (MST1), an
important kinase within the Hippo signaling pathway that controls organ size by
50

promoting apoptosis during development . Caspase-3 cleaves MST1, causing its
51

translocation into the nucleus . DNA damage also induces autophosphorylation of
MST1 on threonine 183, which combines with caspase cleavage to fully activate
52,53

MST1

. Upon activation and nuclear translocation, MST1 phosphorylates histone

H2AX on serine 139 (S139). Phosphorylation of H2AX on S139 is required for DNA
fragmentation and degradation at the end of apoptosis, as it appears to be responsible
for recruiting caspase-activated DNase (CAD) to DNA

51,54

. Histone H2B is also

phosphorylated by MST1 in parallel with H2AX S139 phosphorylation and is responsible
for apoptotic chromatin condensation
terminal kinase (JNK)

55,56

. MST1 can additionally phosphorylate c-Jun N-

57,58

, which can in turn also pan-phosphorylate H2AX-S139

induce DNA fragmentation and chromatin condensation.

11

54

to

1.3 DNA DAMAGE RESPONSE
DNA DSBs activate an intricate network of molecular signaling cascades known as the DNA damage
response (DDR) (Fig. 1.1), which is an intricate network of molecular signaling that enables proper
damage sensing, recruitment of repair factors and DNA repair

22–24

. In mammals, the Mre11–Rad50–

Nbs1 (MRN) complex is involved in the initial sensing of DNA breaks

25,26

. The MRN complex binds broken

DNA ends, holding them together and initiating the prerequisite end processing necessary for repair.
Activation of ATM involves recruitment by MRN to DSBs
1981 and subsequent cleavage of the ATM dimer

26,28,29

25,27,28

together with autophosphorylation at serine

. While the absolute requirements and specific

order of ATM activation steps are unclear due to varying results across different cell types and assay
conditions, the presence of broken DNA ends, the end resection activity of MRN, ATM
autophosphorylation, and ATM monomerization all contribute to the maximal activation of ATM kinase
following DNA damage
γH2AX

62,66

. Activated ATM then phosphorylates histone H2AX on serine 139 to create

67,68

69

, which serves as a docking site for downstream repair factors . ATM is one member of the

phosphatidylinositol 3-kinase-related kinases (PIKKs) along with ATM and Rad3-related (ATR) and DNAdependent protein kinase catalytic subunit (DNA-PKcs). All three PIKKs can compensate for loss of the
others in γH2AX phosphorylation, however ATM is the primary PIKK for DSBs, while ATR is
predominantly involved in signaling and repair of single-strand replication errors
primarily acts through non-homologous end joining DNA repair

71,72

70

and DNA-PKcs

. γH2AX has various important roles in

the DDR, including recruitment of DDR factors, maintaining close proximity of broken DNA ends, signal
73

amplification of the overall DDR response, and directly promoting DNA repair . Mediator of DNA damage
checkpoint protein 1 (MDC1) directly binds γH2AX, recruiting additional MRN and ATM which induces a
positive feedback loop that promotes expansion of γH2AX for megabases around the DNA break and
amplifies the DDR signal

73–75

. Additional DDR factors are also recruited, including several ubiquitin
60

ligases and p53 binding protein 1 (53BP1) among others , leading to activation of biological pathways
such as cell cycle checkpoints and DNA repair. If DNA damage cannot be sufficiently repaired, the DDR
can also induce apoptosis by the activation of p53 through PIKKs and checkpoint proteins

12,76

. Following

completion of DNA repair, various phosphatases act to reverse DDR activation and return the chromatin
to a baseline state

77–83

.
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Figure 1.1. An overview of the DNA Damage Response. This diagram
focuses on some of the important early molecular signaling and downstream
biological outcomes investigated in this project.

1.3.1 Cell Cycle Checkpoints
In addition to phosphorylating H2AX, ATM phosphorylates Chk2 kinase and p53 among other
proteins. Activated Chk2 and ATM stabilize p53 in response to DSBs, leading to transcriptional
activation of the protein p21. p21 blocks cell cycle progression at the G1/S transition by inhibiting
the action of cyclin/cdk complexes, while S-phase entry is further blocked through the
degradation of cell division cycle 25A (Cdc25A) and other cyclins by ATM/Chk2. Chk1 is activated
by ATR, which is most active during S phase, and both Chk1 and Chk2 can phosphorylate Wee1
to block further cell cycle progression during S phase. Wee1 is also involved in G2 arrest,
together with ATR and Chk1. G1 checkpoint arrest factors also play a role in initiating G2 arrest,
but ATR and Chk1 are responsible for its maintenance
13

84,85

, while Cdc25A inhibition is also

involved. Multiple cell cycle and other factors combine to mute the DDR response during
mitosis

38,86

. In general cell cycle checkpoint proteins have primary roles during particular cell

cycle phases, however they function together to promote arrest throughout the cell cycle.

1.3.2 DSB Repair
DNA DSBs are typically repaired through one of two pathways, non-homologous end joining
(NHEJ) or homologous recombination (HR). NHEJ is a rapid process occurring primarily during
G1 phase of the cell cycle. NHEJ is typically completed within 30min of DSB induction, however it
is error-prone and can lead to mutations. HR in contrast is error free due to its utilization of a
template DNA strand, however it can therefore only occur efficiently during S/G2 when sister DNA
strands are available and usually requires several hours to complete

1,87

. NHEJ begins with the

Ku70/80 heterodimer binding the broken DNA ends and subsequently recruiting DNA-PKcs. The
MRN complex aids with recruiting repair factors and processing broken DNA ends together with
the protein Artemis

88,89

, while a complex of proteins involving DNA ligase IV and X-ray repair

cross-complementing protein 4 (XRCC4) ligates the broken DNA ends together

1,59

. HR is a

relatively more complex process, beginning with the processing of DNA to create single-stranded
59

overhangs by MRN and various nucleases . This single-stranded DNA is bound by replication
protein A (RPA) and Rad51 as strand invasion occurs through the homologous template aided by
other proteins such as breast cancer (BRCA)1/2 and Rad54, followed by DNA synthesis and
resolution of the DNA junctions

1,59

.

1.4 STEM CELLS
Stem cells are non-specialized cell types that have the capacity to undergo asymmetric cell division,
producing both a differentiated daughter cell and an identical daughter stem cell. Daughter cells are
90

capable of differentiating into any cell type within their defined lineage and tissue type . Pluripotent stem
cells such as embryonic stem (ES) cells are theoretically capable of producing progeny that differentiate
91

into any cell type , while tissue-specific or adult stem cells are multipotent and are restricted to
differentiate only into cell types of that tissue. Tissue-specific stem cells exist within well-defined niches,
14

a microenvironment consisting of surrounding support cells and differentiated progenitors. Stem cell
function and regulation is controlled by signals from the surrounding niche as well as its internal signaling.
These niches also regulate the proliferation of stem cells

90,92

.

1.4.1 Stem Cell Epigenetics
Stem cell pluripotency and overall gene expression is dictated by their epigenetic profile. Stem
cells exhibit unique epigenetic regulation, including DNA hypomethylation, large areas of
euchromatin and enhanced levels of specific histone modifications. DNA is wrapped and
compacted around proteins known as histones within the nucleus to create a DNA-protein
complex known as chromatin. There are four core histones: H2A, H2B, H3, and H4, in addition to
several histone variants. Post-translational modifications on these histones can regulate gene
transcription, and stem cells exhibit distinctive modulation of histone modifications that can
control their pluripotency. Pluripotency is associated with enrichment of both the activating mark
histone 3 lysine 4 methylation as well as the repressive mark histone 3 lysine 27 methylation.
This dual signature known as the “bivalent” chromatin structure maintains ES cells in a poised
state for rapid transcription upon differentiation stimuli. Histone 3 lysine 4 methylation in particular
gene regions is associated with reduced DNA methylation, which is repressive for transcription,
further demonstrating the bivalent regulation of gene expression in stem cells. Histone 3 lysine
56 acetylation is also greatly elevated in embryonic stem cells and promotes expression of
pluripotency genes

93,94

.

1.4.2 Proliferation and Cell Cycle in Stem Cells
Many stem cell compartments contain both non-dividing quiescent stem cell populations as well
as an additional pool of actively dividing stem cells. These populations may be differentially
92

involved in tissue regeneration following injury versus normal tissue turnover and homeostasis .
Embryonic stem cells are rapidly proliferating, and this rapid proliferation appears to be an
important characteristic of pluripotency. Additionally, embryonic stem cells exhibit a shortened G1
cell cycle phase that may also be involved in maintaining their undifferentiated state
15

95–97

.

Following DNA damage, both embryonic and neural stem cells both uniquely fail to activate G1
checkpoint arrest

95,96,98–101

. The lack of G1 arrest in ES cells is associated with cytoplasmic

sequestration of p53

102

and Chk2

99

. p21 protein is also absent in ES and neural stem cells,

despite the expression of p21 mRNA

96,98,100,103

.

1.4.3 Maintaining Genomic Stability in Stem Cells
Since stem cells are responsible for regenerating all of the differentiated cell types of a tissue,
maintaining their genomic integrity is imperative. Stem cells therefore exhibit multiple
mechanisms for promoting genomic stability. One method for preventing genomic instability in
stem cells is elevated antioxidant defenses. ES cells are resistant to high levels of damaging
reactive oxygen species (ROS) due to higher expression of ROS-inactivating enzymes and
maintain lower endogenous ROS levels than differentiated cells

104,105

. They also show high

expression of transporter and efflux pumps that can remove potentially damaging chemicals from
104

the cell

. ES cells additionally express higher levels of heat shock proteins, which protect

against the misfolding of proteins following cellular stress. As another mechanism of genome
protection, ES cells exhibit a low mutation rate, with baseline mutation frequencies up to 1000
fold less than murine embryonic fibroblasts, at least at certain loci

105,106

.

1.4.3.1 DNA Damage Sensitivity
While embryonic stem cells demonstrate robust mechanisms for maintaining genomic
stability under baseline conditions, ES and neural stem cells in culture are extremely
sensitive to elevated levels of DNA damage and readily undergo DNA damage-induced
apoptosis

102,105,107–112

. It is often argued that the removal of damaged stem cells from a

population has evolved in order to prevent the perpetuation of genomic instability within a
tissue, which can lead to organ dysfunction or cancer, however this proposal is only
theoretical. ES cells are primed to apoptose by constitutively active Bax
require the upstream apoptotic regulator p53
nucleus in ES cells

99,102

102

105,113

but do not

, which is insufficiently translocated to the

. The absence of a G1 checkpoint may contribute to the
16

sensitivity of ES cells to DNA damage, as restoration of the G1 checkpoint through Chk2
overexpression was able to reduce IR-induced apoptosis in ES cells

99,106

. While p53 may

not be directly related to ES cell apoptosis, p53 can alternatively induce differentiation
following DNA damage by blocking expression of the pluripotency gene Nanog

114

.

Neural stem cells have also been shown to cease dividing and differentiate following
DNA damage

110

.

Tissue-specific stem cells vary in their radiation responses both across different tissues
and among different populations within a particular niche. While the radiosensitivity of
individually labeled neural stem cells in vivo has not been investigated, numerous reports
have observed cell death and reduced proliferation of neural precursors within
hippocampal regions of neurogenesis
undergo IR-induced apoptosis

115–120

. Intestinal crypt stem cells also readily

121,122

, in contrast with stem cells of the colon

123

. The

intestine is now believed to contain multiple stem cell populations and lineages
however

124–126

, each with varying radiosensitivities

127,128

. While testicular stem cell loss

has long been associated with infertility after radiation exposure

129

, labeled

spermatogonial stem cells have in fact been shown to be radioresistant while adjacent
nom-stem spermatogonia undergo IR-induced apoptosis
tissue niches of skin have demonstrated radioresistance

130

. Stem cells within multiple

131,132

, although the hair follicle

niche may contain differentially regulated stem cell populations

133

similar to intestinal

crypts. Mesenchymal stem cells from bone marrow represent another radioresistant stem
cell population

134

, while the relative radiosensitivity of hematopoietic stem cells appears

to be species-dependent

135–137

. While certain characteristics are clearly conserved

among all stem cell populations, it is apparent that stem cell radiation responses are
highly context-dependent.

17

1.4.3.2 DNA Damage Response and DNA Repair
Despite the apoptotic responses of many stem cell populations in response to DNA
damage, most studies report rapid and efficient DNA repair capabilities in stem cells. ES
cells are very efficient at mismatch repair, which is important for fixing base misincorporation and other nucleotide base errors during DNA replication and may account
for their low mutation rate. Limited studies suggest enhanced base excision repair in ES
cells due to elevated expression of repair proteins, which reverses chemical modifications
to DNA as well as single-strand breaks

105

. ES cells are however sensitive to UV-induced

damage, with disagreement among the literature concerning their capacity for nucleotide
excision repair of UV-induced lesions

105,112,138

. There is a great deal of conflicting

information concerning repair of DSBs in ES cells. The majority of studies observed that
both ES and neural stem cells show efficient repair of DSBs

104,109,139–142

. These stem cells

predominantly repair DNA damage through homologous recombination due to their short
G1 and elevated expression of repair factors

143–147

, however efficient NHEJ

139,148,149

also

contributes to their DNA repair efficiency. In agreement with these studies, robust DDR
induction has also been shown in cultured embryonic and neural stem
cells

101,109,111,144,150,151

. Despite strong evidence for efficient DDR signaling and DNA

repair in stem cells, multiple studies also report that stem cells exhibit reduced DNA
repair capacity. Differences appear to exist between mouse and human stem cells

107

; in

fact one study found murine but not human ES cells to be deficient in repairing DNA
breaks

152

. Murine induced pluripotent stem cells have also been found to exhibit

inadequate H2AX phosphorylation and DNA repair

153

, and one of the few studies to

actually compare stem cells with isogenic progeny observed that ES cells were less
efficient at both induction and resolution of γH2AX foci

154

. Unirradiated ES cell lines

exhibit high basal γH2AX which is believed to be important for regulating self155,156

renewal

, but this basal γH2AX appears to be independent of DDR signaling

18

157

.

The molecular signaling occurring within tissue stem cells in response to DNA damage is
sometimes contradictory with their overall radiosensitivity. DDR foci have been observed
in intestinal crypt stem cells

158,159

despite the presence of IR-induced apoptosis in those

same cells. Similarly, while spermatogonial stem cells of testis were shown to be
radioresistant, they fail to display γH2AX or MDC1 foci correlating with reduced DNA
repair based on 53BP1 foci resolution

130

. The DDR has not been well-detailed in neural

stem cells in vivo, as previous studies have investigated the DDR principally within
developmental contexts

103,160

without the use of stem cell markers. Limited evidence from

existing studies actually shows enhanced DDR foci and anti-apoptotic protein
103

expression

, in contrast with radiosensitivity data from other publications. Both
134,161

mesenchymal

and hair follicle

132

stem cells show elevated DDR and DNA repair

capacity in agreement with their radiosensitivity data, and HSC molecular radiation
responses were again species-dependent

135–137

.

1.5 DNA DAMAGE-RESPONSIVE HISTONE MODIFICATIONS
DNA damage induces substantial changes in chromatin, both globally and around DNA break sites.
Specific histone modifications may play a role in all aspects of DNA repair, including controlling access of
repair factors to DNA, signaling through the DNA Damage Response, transcriptional repression and
reassembly of chromatin following repair

162–164

. Numerous histone modifications have been identified that

are either beneficial or detrimental toward DNA repair signaling, and I will focus on a few relevant for this
study.

1.5.1 H2AX S139
Histone H2AX is phosphorylated by ATM at serine 139 (S139) to create γH2AX as part of the
67

DNA Damage Response , serving as a docking site for downstream DDR signaling and
promoting DNA repair. While γH2AX foci around DSBs is the primary function of H2AX S139
phosphorylation, pan-nuclear H2AX S139 phosphorylation (H2AX-pS139) has been observed in
response to both DNA damaging agents and other stimuli
19

165,166

. This pan-nuclear H2AX-pS139

has been attributed to diffusion of DDR factors, creation of small DNA fragments, global
chromatin changes, viral infection and apoptosis in various contexts. Apoptotic H2AX-S139
forms a ring or pan-nuclear stain around the nucleus following induction of apoptosis. Reports
vary in reporting whether the PIKK proteins ATM and DNA-PKcs
51,57

MST1

54

and JNK

55

or the apoptotic factors

are responsible for apoptotic H2AX-S139 phosphorylation. H2AX-pS139 is

required for DNA fragmentation and degradation at the end of apoptosis, likely acting through the
recruitment of caspase-associated DNases

51,54

. H2AX-pS139 also interacts with AIF in order to

degrade DNA as part of a programmed necrosis cell death pathway

167

. This apoptotic H2AX-

S139 does not include MDC1 or 53BP1 and is associated with inhibition of DDR amplification due
to inactivating caspase-mediated cleavage of MDC1

165,168

.

1.5.2 H2AX Y142
The tyrosine 142 (Y142) residue on histone H2AX is also an important regulator of molecular
responses to DNA damage. H2AX-Y142 phosphorylation (H2AX-pY142) is mediated by WSTF
kinase

169

and EYA phosphatase

170

. H2AX-pY142 is inversely regulated with H2AX-pS139, as

Y142 is phosphorylated under basal conditions and is dephosphorylated following DNA damage,
paralleling γH2AX induction

169,170

. Basal H2AX-pY142 is necessary for maintenance of normal

DDR signaling in response to DNA damage

169

, whereas removal of Y142 phosphorylation is

required for MDC1 binding to γH2AX and subsequent DDR amplification. In addition to blocking
DNA repair signaling, the presence of H2AX-pY142 following induction of DSBs instead recruits
apoptotic factors, leading to induction of apoptosis through JNK

170

. The structure of the Y142
171,172

residue itself also appears to be important for normal DDR signaling and radiosensitivity

.

Additionally, both IR and drug-induced apoptosis may involve co-regulation of the H2AX S139
and Y142 residues

172,173

.

1.5.3 H3K56ac
Histone 3 lysine 56 acetylation (H3K56ac) has been identified as an important DNA damageresponsive histone modification that may play a substantial role in DDR signaling and chromatin
20

structure around DNA breaks. Several studies have assessed global changes in H3K56ac levels
in response to genotoxic stress, with contradictory results concerning whether levels increase
176

or decrease

174–

177–179

. In yeast, H3K56ac promotes deposition of H3 histones on to chromatin

during DNA replication and following repair

180–183

, promoting genomic stability. H3K56ac has also

been shown to be enhanced during S phase and beneficial for genomic stability in mammals

184

.

In contrast, H3K56ac is reduced at DSB sites and constitutively enhanced H3K56ac may impair
NHEJ and break-induced replication by blocking resolution of repair factor foci

177,185

. Temporal

evidence suggests that these contrasting results are due to a biphasic response of H3K56ac
exhibits a biphasic response following DNA damage

177,186

. Proper initiation of DDR signaling and

DNA repair factor recruitment may therefore require initial reduction of H3K56ac levels followed
by rapid restoration of H3K56ac to restore the basal chromatin configuration state and complete
DNA repair

177,186

.

1.5.3.1 Regulators of H3K56ac
Several acetyltransferases and deacetylases have been associated with H3K56ac. In
yeast, H3K56ac is acetylated by Rtt109 and deacetylated by the surtuin family homologs
hybrid sterility (Hst)3 and Hst4

181,183,187

in mammalian cells, as both GCN5

178

. H3K56ac regulation appears to me more complex

and CREB-binding protein (CBP)/p300

174,175

have

been identified as relevant acetyltransferases. Conserved in both yeast and mammalian
cells is the requirement of the histone chaperone Anti-silencing function protein 1 (Asf1)
(ASF1A in mammals)

174,181,183,186,188

, which directs CBP/p300 to chromatin and promotes

their interaction with H3K56ac. Several deacetylases for H3K56 have been identified as
well in human cells. In addition to histone deacetylase (HDAC)1 and HDAC2

177

multiple

sirtuin family members have been associated with H3K56 deacetylation, namely sirtuin
(SIRT)1 and SIRT2

174,184

as well as SIRT6

21

189

.

1.5.3.1.1 p300/CBP
p300 and CBP are closely related nuclear proteins. In addition to their role as
histone acetyltransferases, p300 and CBP also act as transcriptional coactivators
by directing assembly of transcriptional machinery at promoter regions

190,191

.

Genomic localization of p300 binding elucidated that p300 is predominantly
recruited to pluripotency genes in ES cells
H3K56ac at pluripotency gene promoters
regulation of ES differentiation

193

192

, mirroring the enrichment of

93,94

. p300 is also necessary for proper

. p300 and CBP also play a role in the induction

of apoptosis, primarily through their regulation of p53. p300 binding to p53 may
promote its degradation under basal conditions, but upon cellular stress
p300/CBP acetylation of p53 promotes p53 transcriptional activation of target
genes

190,194–196

. Additionally, p300 and CBP are also mutated in many cancers

197

and p300 (but not CBP) loss has been shown to impair apoptosis in culture
cells

198

.

1.6 PROJECT SUMMARY
The goals of my thesis research were to identify the molecular basis for stem cell radiation responses.
Unintended sequelae resulting from radiation therapy have been attributed to the loss of tissue
regenerative potential. While there are many mechanisms of radiation-induced normal tissue injury, my
project exclusively investigated stem cell dropout, which affects all actively proliferating and regenerative
tissues. Destruction of stem cell compartments leads to progressive loss of tissue function and integrity
due to dysregulation of normal tissue turnover as differentiated functional tissue compartments are unable
to be replenished over time. The clinical motivation underlying this dissertation is to understand the
cellular targets of radiation damage and the molecular mechanisms underlying this radiosensitivity. My
thesis work began by confirming that only stem cells undergo programmed cell death following exposure
to therapeutic IR doses, while surrounding differentiated cells within the niche are radioresistant. The
primary focus of my project was then to elucidate the molecular mechanisms responsible for this
differential radiosensitivity among stem and differentiated cells. My studies focus on differences in DNA
22

Damage Response signaling and regulation of histone modifications that contribute to stem cell IR
hypersensitivity.

Since stem cells are responsible for generating all differentiated cell types of a tissue, maintaining
genomic integrity is of utmost importance to ensure that mutations are not passed on to future progeny.
Identifying the details of stem cell responses to DNA damage has therefore been a popular research
topic. However, the vast majority of studies previously performed only focused on a particular stem cell
model, either in culture or within a specific tissue niche. This precludes identifying broadly applicable
mechanisms concerning stem cell radiation responses that are conserved across multiple tissue types.
We therefore utilized multiple clinically relevant stem cell niches in order to identify molecular
mechanisms responsible for IR-induced normal tissue injury. We assessed cell death and DDR signaling
in the dentate gyrus of brain, seminiferous tubules in testis, intestinal crypts and hair follicles. There has
also been a stark lack of emphasis in the literature on the use of primary, early passage culture cells.
Stem cells can rapidly evolve genomic and epigenomic changes upon culturing

199,200

that may result in

modified stem cell molecular responses to DNA damage, so avoiding extended passage of cells is
essential. The majority of published studies also do not compare cultured stem cells with directly
differentiated, isogenic progeny. This introduces additional complications such as strain variation, cell
type-specific differences and additional culture artifacts from the use of established cell lines. We wanted
to study stem cell radioresponses together both in vivo and in culture, so we took great efforts to establish
primary culture models that recapitulate observed in vivo phenomena. We established two culture
models, murine embryonic stem cells (ES) and neural stem cells (NS). ES cells were primarily purchased
from American Type Culture Collection (ATCC) or the Washington University Murine Embryonic Stem
Cell Core for convenience, but are originally isolated from the inner cell mass of 4.5 day old blastocysts,
while we isolate neural stem cells ourselves from the hippocampus of P0-P2 neonatal mice. ES and NS
cells are non-specifically differentiated by removal of LIF or EGF/FGF, respectively, from media
conditions (Fig. 1.2). Differentiated ES cells (ED) take on a fibroblast-like appearance while differentiated
NS cells (ND) are mixed but biased towards astrocytic differentiation due to supplementation with serum
201

to promote proliferation

. We utilized non-targeted differentiation because we are interested in the effect
23

of merely losing stemness as opposed to any lineage-specific phenotypes. Through establishing this
culture system, we have been able to more accurately assess the role of differentiation state in dictating
radiation responses.

The first chapter of my thesis analyzes the relative radiosensitivity of stem cells as compared to their
differentiated progeny. The remaining two chapters examine the molecular mechanisms underlying the
observed differential radiosensitivity between stem and differentiated cells. We first compared induction of
the DDR and DNA repair between stem and differentiated cells in order to determine whether inhibited
signaling responses to DNA damage could contribute to increased radiosensitivity. Since the purpose of
our experimental design was to discover conserved IR-phenotypes linked specifically to differentiation
status, we wished to examine molecular regulators of stemness that could also potentially influence
radiosensitivity or the DDR. Cell type and differentiation status are determined by unique transcriptional
programs that are controlled by specific combinations of histone modifications

202

. In addition to

controlling binding of transcription factors to DNA, histone modifications can also regulate access of
repair factors. Differentiation status, epigenetic profiles and DNA repair signaling are thus all related (Fig.
1.3). My thesis attempts to define the connections between these features and how they can characterize
cellular radiosensitivity. A better understanding of the molecular mechanisms underlying radiation
responses of stem and differentiated cells will promote future targeted therapies for reducing detrimental
sequelae in patients.

24

Figure 1.2. Primary stem cell culture models utilized in this study.

Figure 1.3. The interrelatedness of the DDR, differentiation state and epigenetics in
controlling cellular radiosensitivity.
25
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CHAPTER 2
Stem Cells are Radiosensitive in Contrast with
their Differentiated Progeny
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2.1 ABSTRACT
The exposure of normal tissue to ionizing radiation (IR) during radiotherapy for cancer treatment leads to
undesired sequelae. Normal tissue injury resulting from ionizing radiation (IR) during cancer radiotherapy
has been in part attributed to reduced regenerative capacity of tissues. Utilizing multiple in vivo tissue
niches and culture models, we demonstrate that normal stem cells are highly radiosensitive while their
isogenic differentiated progeny are radioresistant. Stem cell apoptosis is associated with differential
induction of pro- and anti-apoptotic proteins, occurs in all cell cycle phases and is independent of
proliferation status. By determining that normal tissue injury involves loss of individual stem cells within
their respective niches and not the entire stem cell compartment, this work has identified potential targets
for future therapeutic intervention. By inhibiting these apoptotic pathways in stem cells specifically,
strategies may be developed for minimizing side effects from radiation therapy.

2.2 METHODS
2.2.1 Cell Lines and Differentiation
Karyotypically normal early passage ES cells (EDJ22) were obtained from the Murine Embryonic
Stem Cell Core of Siteman Cancer Center at Washington University. ES cells were grown on
gelatin-coated plates, and maintained in stem cell culture media containing Knockout DMEM, 10
ng/ml leukemia inhibitory factor (LIF), 2 mM L-glutamine (Invitrogen), non-essential amino acids
MEM (Corning), 15 % FBS, 0.2 % β-mercaptoethanol, 1 % penicillin/streptomycin and 40 μg/ml
gentamicin (Invitrogen) and not used for more than 5 passages. Cells were passaged every 2
days using 0.05%Trypsin/0.53mM EDTA (Corning). Differentiated cells (ED) were generated by
culturing ES cells in media lacking LIF for 5-7 days. Neural stem (NS) cells were isolated from
dentate gyri of late stage mouse embryos (E15-E18) or new born pups (P0-P1) and cultured in
neural stem cell media containing Knockout DMEM/F-12 containing 15 mM Hepes (Stem Cell
Technologies) with 1% N2 supplement, 2 % B27 supplement, 10ng/ml bFGF, 20ng /ml EGF, 1 %
penicillin/streptomycin and 40 μg/ml gentamicin (Invitrogen) and thereafter differentiated in the
absence of EGF/FGF growth factors with addition of 10% FBS (Hyclone) for ~7 days.
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2.2.2 Animal Models
Mouse strain C57BL/6 was used for all animal studies. Adult 6-8 week old males were utilized for
harvest of brain, intestine, skin and testis for sectioning. For breeding, 1-6 month old male and
female mice of similar age were allowed to mate continuously, with pregnant females isolated
independently before giving birth. P0-P2 mouse pups were sacrificed by rapid decapitation prior
to dissection for neural stem cell isolation. Procedures for all studies were been approved by the
Animal Studies Committee at Washington University Medical Center.

2.2.3 Antibodies
Details of the antibodies used in this work are described in Table 2.1.

Table 2.1. Antibody Information Table
Protein Target

Species

Company

Catalog #

Assay

Conditions

Bax

mouse

Santa Cruz

sc-7480

WB

1:250 in milk

Bcl2
BrdU (AlexaFluor 488
conjugated)

rabbit

Cell Signaling

#2870

WB

1:100 in milk

mouse

Invitrogen

B35139

FACS

cleaved Caspase-3

rabbit

Cell Signaling

#9664

IHC-F, WB

1:20
1:500, 1:500
in milk

Cleaved PARP

mouse

BD Biosciences

51-9000017

IHC-F

1:100

Ki67

rabbit

NeoMarkers

RB-1510-P0

IHC-F

1:100

Lin28

rabbit

Abcam

ab46020

WB

1:1000 in milk

Nanog

rabbit

Abcam

ab80892

WB

1:1000 in milk

Oct4

rabbit

Abcam

ab19857

IF, IHC-F

1:200, 1:200

PARP

rabbit

Cell Signaling

#9542

WB

1:2000 in milk

PCNA

mouse

Millipore

NA-03

IHC-F

1:100

Pro Caspase-3

rabbit

Cell Signaling

#9665

WB

1:1000

Sox2

rabbit

Abcam

ab7959

IHC-F

1:100

Sox2

mouse

Abcam

ab79351

IF, IHC-F

1:200, 1:100

SSEA1

mouse

Abcam

ab16285

IHC-F

GAPDH
FITC-conjugated antirabbit
FITC-conjugated antimouse
Texas Red-conjugated
anti-mouse
Texas Red-conjugated
anti-rabbit

mouse

Sigma Aldrich

G8795

WB

1:100
1:100,000 in
milk

donkey

Vector

FI-1000

IF, IHC-F

1:100

horse

Vector

FI-2000

IF, IHC-F

1:100

horse

Vector

TI-2000

IF, IHC-F

1:100

donkey

Vector

TI-1000

IF, IHC-F

1:100
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HRP-conjugated antimouse
HRP-conjugated antirabbit

rabbit

Sigma Aldrich

A9044

WB

1:5000 in milk

goat

Sigma Aldrich

A0545

WB

1:5000 in milk

2.2.4 X-Ray Irradiation and Tissue Sectioning
Cells and animals were irradiated in the RS-2000 Biological Research Irradiator (Rad-Source) at
room temperature, with mock/control irradiated samples brought into the room to simulate the
reduction in ambient temperature and account for any stress imparted by the travel. Cells were
always placed within the central circle directly under the x-ray source to maintain consistency in
dose between samples. Animals were anesthetized with isofluorane and placed on their back in
the machine for whole-body irradiation to properly expose all tissues of interest to the x-ray
source. Accuracy of all doses was confirmed by dosimeter probe. Both cells and animals were
randomly assigned to individual timepoints or sham-irradiation controls.

Following irradiation, mice were sacrificed at specific timepoints by CO 2 asphyxiation and cervical
dislocation. Organs were harvested, placed in OCT media and frozen in liquid nitrogen. Frozen
tissues were sectioned on a cryostat machine at a thickness of 10 μm, placed onto adhesive
o

slides and stored at -80 C.

2.2.5 Apoptosis Assays (TUNEL, Annexin V, Annexin XII/ pSIVA)
Apoptosis in tissue sections (staining and microscopy) and cultured cells (flowcytometry), were
analyzed using various assays such as TUNEL, Annexin V, and Annexin XII following
manufacturer’s protocol. In cultured cells, APO-BrdU TUNEL Assay kit with Alexa Fluor 488 AntiBrdu (Invitrogen) was used for TUNEL assay, Annexin- V FITC detection kit (BD Pharmingen)
was used for Annexin V staining, and GLO pSIVA-IANBD Apoptosis / Viability Flow Kit (Imgenex)
for Annexin XII staining. 10,000 cells were counted for flow cytometry analysis. TUNEL staining
on tissue sections was performed with the DeadEND fluorescent TUNEL system (Promega).
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2.2.6 Western blotting
Cellular protein lysates were collected in RIPA buffer, electrophoresed on 4-15 % Tris-Glycine
polyacrylamide gels (BioRad), transferred onto PVDF membranes and after blocking with 5 %
o

BSA or milk in TBS-T incubated overnight at 4 C with various primary antibodies followed by
secondary antibody incubation. Super ECL (GE/Pierce) was used as substrate for detection on
autoradiography film or ChemiDoc MP digital system (BioRad).

2.2.7 Immunofluorescent Staining
Cryosections were fixed in 4 % formaldehyde, permeabilized with 0.2 % Triton-X 100 (Sigma),
blocked in 2 % BSA in PBS, probed using primary antibodies and detected using 5 μg/ml
secondary antibodies labeled with FITC or TexasRed (Vector Labs). After mounting in
Vectashield mounting media containing DAPI (Vector Labs), microscopic observations, scoring
and quantifications were done and fluorescent images were taken.

Cells were similarly fixed in 4% formaldehyde and permeabilized with 0.2% Triton-X 100 before
blocking in 2 % BSA and antibody incubation. For double-color staining, primary antibodies were
o

incubated together for 1h at 37 C followed by wash and incubation with fluorescently-tagged
o

secondary antibodies for 30 min at 37 C.

2.2.8 Clonogenic Survival Assay
Cells were used in a colony formation assay to measure cell survival after IR treatment using
standard protocols. Cells were plated, irradiated at various doses and allowed to grow for 7 to 14
days. Any colonies formed were fixed and stained with crystal violet (Sigma). The number of
colonies (with >50 cells) per dish was counted, and the surviving fractions were calculated as the
ratio of the plating efficiencies of treated cells to untreated cells.
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2.2.9 Neutral Comet Assay
To assess and quantify DNA breaks and apoptotic fragmentation of DNA, neutral comet assays
were performed using CometSlide assay kits (Trevigen). Cells were irradiated with 6 Gy, lysed,
electrophoresed in agarose in TAE buffer and stained with SYBR Green (Trevigen). Olive
moment of the comets was calculated by multiplying the percentage of DNA in the tail by the
displacement between the means of the head and tail distributions. CometScore™ Version 1.5
(TriTek) was used to calculate Olive Moment. A total of 50–75 comets were scored and analyzed
per sample in each experiment with each series of timepoints repeated at least three independent
times as both biological and technical replicates. Individual comets were randomly selected for
scoring from similar regions of the slide in all samples. Outliers were eliminated that fell greater
than 1.5 standard deviations from the mean. Data from all samples was approximately normally
distributed, and the standard deviation between samples within the same experiment was similar.
Samples were excluded from analysis only due to technical errors from the assay or cells being
visibly unhealthy.

2.2.10 Cell Cycle Analysis
o

For phase-specificity of apoptosis, live cells were incubated for 1h at 37 C with Vibrant FAM
Caspase-3 and 7 FLICA reagent (Invitrogen). Cells were subsequently fixed for 15min with 4%
o

o

formaldehyde at 4 C prior to overnight ethanol fixation at -20 C in order to preserve cytoplasmic
contents during ethanol permabolization. Fixed cells were subsequently incubated with RNase
and propidium iodide followed by flow cytometric analysis. Total and apoptotic populations were
gated for each cell cycle phase, and the ratio of apoptotic to total cells within each phase was
obtained.

ES and ED cells were incubated with 20μM BrdU (Sigma) for 30min, washed 2 times and chased
for various timepoints to allow cell cycle progression. Cells were then fixed overnight in ethanol at
o

-20 C, incubated with RNase and propidium iodide, and analyzed by flow cytometry. For in vivo
BrdU incorporation, 100ul of 10mg/ml BrdU was injected intraperitoneally. Mice were sacrificed
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after 72h, and skin sections were isolated for frozen sectioning. BrdU incorporation into skin was
detected by immunofluorescence.

2.2.11 Viability Assay
Cells were plated in equal numbers onto dishes and were either allowed to grow for 24-48hr (ES)
or differentiated for 3-4 days. Cells were then irradiated with 6Gy and incubated for the specified
period of time. Cells were harvested by trypsinization into single-cell suspensions and counted on
the Vi-Cell Viability Analyzer (Beckman Coulter) by trypan blue incorporation. At least 100,000
cells were counted per sample.

2.2.12 Microscopy and Image Processing
Micrographs were captured utilizing MetaSystems ISIS imaging software on Zeiss Axioplan2
microscope or ZEN software on Zeiss LSM510 confocal microscope with the 20x, 63x or 100x
objective lenses. Minimal threshold and contrast manipulation was performed equally across
entire images. Controls were processed equally with treated samples. Adobe Photoshop CS3
software was utilized for composing the collages of multiple pictures and labeling micrographs
and Immunoblots in individual layers.

2.2.13 Statistical Analysis
A ‘two-tailed’ Student's t-test was used to calculate the statistical significance of the observed
differences. In all cases, differences were considered statistically significant when p<0.05.
Unless otherwise indicated, values represent mean ± SEM.

2.3 INTRODUCTION
Radiation therapy utilizes ionizing radiation (IR) to produce lethal DNA double-strand breaks (DSBs) in
1

cancer cells; however detrimental side effects often result from unintended damage to normal tissue .
Patients undergoing radiotherapy experience acute and chronic sequelae such as hair loss, skin
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regeneration defects, erosion of intestinal epithelium, malabsorption, hematopoietic anomalies, infertility,
and neurocognitive impairments

1–5

. Normal tissue injury following radiotherapy has been attributed to the
6,7

loss of regenerative capacity in stem cell compartments , however the molecular details of normal stem
cell radiosensitivity remain unclear.

Ionizing radiation (IR)-induced cell death is caused by DNA damage, especially complex DNA double
8

strand breaks . Under tolerable ranges, damaged DNA is efficiently repaired, but if beyond the repairable
state or in the event that the DNA repair process is hampered, cells either stop dividing or undergo
9

programmed cell death . Cells vary in their response to DNA damage depending on the cell type,
10

differentiation status, proliferation state and cell cycle stage . An improved understanding of cellular
radiation responses is essential for the development of strategies to protect normal tissue during
radiotherapy. However, despite indications for stem cells playing a role in normal tissue injury resulting
11–13

from radiotherapy

studies on the relative radiosensitivity of stem cells remain debatable at

experimental and molecular mechanistic levels. While many investigators acknowledge high
radiosensitivity in stem cells

14–19

other reports show relative radioresistance

20–22

. There is, however, a lack

of direct comparison of differential radiation responses in stem and differentiated cells in vivo and of stem
cells with their isogenic progeny in cell culture models. Moreover, the usage of primary, early passage
cells could avoid possible culture artifacts. Further, the molecular mechanisms of differential
radiosensitivities must be elucidated to develop therapeutics that minimize stem cell drop-out and
resulting radiation damage to the normal tissue.

We demonstrate that stem cells are hypersensitive to relatively low dose IR both in vivo in normal stem
niches of various tissues as well as in karyotypically normal, early passage primary mouse embryonic and
neural stem cells as compared to their isogenic differentiated progeny. IR-induced apoptosis in stem cells
occurs within few hours after irradiation and involves the action of various apoptotic factors. This
apoptotsis is broadly distributed across the cell cycle in stem cells, while differentiated cells apoptose
primarily during G2/M phase. The observed differential radiosensitivity between stem and differentiated

45

cells is not due to enhanced proliferation in stem cells, suggesting that enhanced radiosensitivity is
inherent to an undifferentiated cell state.

2.4 RESULTS
2.4.1 Normal stem cells in vivo are radiation hypersensitive while surrounding non-stem
cells are relatively radioresistant
To analyze the radiosensitivity of stem cells compared to differentiated non-stem cells in vivo,
C57BL/6 male mice were whole-body irradiated and observed for apoptosis in the stem cell
niches of the subgranular (SGZ) and subventricular zones (SVZ) in brain, hair follicle bulge in
skin, intestinal crypt and seminiferous tubules of testis. The selected stem cell compartments are
located within four clinically relevant tissues that each exhibit deleterious consequences from
radiation therapy. A dose curve was performed from 0-10Gy and apoptosis was observed in each
niche relative to labeled stem cells at 6h, 12, 24h and 48h following irradiation. Apoptosis was
exclusive to individually stem cells within all niches at lower doses as indicated by various
markers, and almost every stem cell present was undergoing cell death at 6Gy (Fig. 2.1, 2.2).
Apoptosis was not observed in any unirradiated samples (Fig. 2.2, 2.3). While apoptosis was
observed in stem cells following exposures to as low as 2Gy IR, only minimal apoptosis was seen
in differentiated cells at doses 8Gy and above. These data establish that stem and differentiated
cells exhibit varying thresholds for responding to DNA damage.
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Figure 2.1. IR-induced apoptosis is exlusive to stem cells in vivo. Immunofluorescence co-staining of
stem cell markers (red; Sox2, Stage-specific embryonic antigen 1 [SSEA1], Oct4) and apoptosis markers
(green; c-PARP, CC-3,) in tissue niches 12h following 6Gy whole body irradiation. Green and red arrows
indicate cells positive for both stem cell marker and apoptosis marker. DAPI=DNA. SVZ=subventricular
zone; SGZ=subgranular zone. CC-3=cleaved caspase-3; c-PARP=cleaved Poly ADP-ribose polymerase
(PARP). White scale bars, 10µm.

Figure 2.2. Dose curve of IR-induced apoptosis among stem and non-stem cells in vivo. The
percentage of apoptotic stem and non-stem cells was measured at 12h after incremental irradiation
doses. Stem and non-stem cells were scored within the entire intestinal crypt and proliferative zone of
the villus. No apoptosis was observed in the terminally differentiated upper villus. N=3 (combined
counting of 3 sections each from 3 independent mice). Error bars indicate SEM.
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Figure 2.3. In vivo sham irradiation apoptosis negative controls. Immunofluorescence co-staining of
stem cell markers (red; Sox2, SSEA1, Oct4) and apoptosis markers (green; c-PARP, CC-3, TUNEL) in
tissue niches 12h following 0Gy sham whole body irradiation. DAPI=DNA. CC-3=cleaved caspase-3; cPARP=cleaved PARP. White scale bars, 10µm.

2.4.2 Radiation hypersensitivity is recapitulated by primary embryonic and neuronal stem
cells in culture
We also established two sets of karyotypically normal, early passage, primary cell culture models
in mouse embryonic stem cells (ES) and neural stem cells (NS) along with their isogenic
differentiated non-stem counterparts (ED and ND, respectively). Both stem cell models were
directly differentiated by passage in the absence of specific growth factors (Fig. 2.4 A-B).
Radiation responses of stem cells could thus be assessed in parallel with their isogenic, recently
differentiated progeny in order to compare outcomes. ES cells demonstrated a progressive linear
decrease in viable cell number across multiple timepoints following 6Gy irradiation (Fig. 2.5).
Significantly higher levels of apoptosis were detected in both cell culture models compared to
their differentiated progeny following 6Gy IR (Fig. 2.6 A-C). Clonogenic survival curves confirmed
logarithmic higher rates of cell killing in stem cells compared to non-stem cells at all doses,
accounting for both cell death and senescence in measuring cellular replicative capacity following
irradiation (Fig. 2.7). DNA fragmentation is among the final steps of apoptosis as the nucleus is
degraded by caspases and DNases. As a further indicator of apoptosis, we utilized comet assays
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to assess late-stage apoptotic DNA fragmentation. Comet assays employed single-cell gel
electrophoresis following irradiation and nuclear lysis. Differentiated cells displayed progressive
reduction of DNA breaks over time following irradiation, whereas DNA breaks in stem cells starkly
increased beginning at 8h post-IR consistent with apoptotic DNA fragmentation (Fig. 2.8 A-B).
The apoptotic effectors of cleaved poly ADP-ribose polymerase (PARP) and caspase-3 were also
detected exclusively in stem cells beginning 4h post-irradiation. Additionally, differential levels of
pro- and anti-apoptotic Bcl-2 family member proteins were observed in stem and non-stem cells.
Pro-apoptotic Bax was higher in ES cells and increased upon irradiation, while the anti-apoptotic
Bcl-2 showed higher expression in ED cells (Fig. 3.9 A-B). These results demonstrate that stem
cells are substantially more radiosensitive than non-stem differentiated cells and readily undergo
IR-induced cell death.

Figure 2.4. Differentiation of stem cell culture models. (A) Bright field images and
immunofluorescence staining for stem cell markers (green; Oct4, Sox2) demonstrating differentiation of
ES cells into ED cells and NS cells into ND cells. DAPI=DNA. White scale bars, 10µm. (B) Western blots
for stem cell markers on unirradiated ES, ED, NS and ND. GAPDH served as a loading control.
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Figure 2.5. Differential viability of ES and ED cells following irradiation. ES and ED cells were
irradiated with 6Gy during exponential growth and incubated for the indicated times prior to viability
counting by trypan blue incorporation. N=3. Error bars indicate SEM.

50

Figure 2.6. Stem cells but not directly differentiated progeny undergo IR-induced apoptosis in
culture. Flow cytometric analysis of apoptosis comparing ES and ED or NS and ND cells by (A) AnnexinV, (B) Annexin-XII, and (C) TUNEL labeling following sham or 6Gy IR at indicated timepoints. N=3; * = p <
0.05; ** = p < 0.01; otherwise not significant.
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Figure 2.7. Clonogenic survival of cell culture models after various IR
doses. ES, ED, NS and ND cells were irradiated 6h after plating. N =3.
Error bars indicate SEM.

Figure 2.8. Neutral comet assay on cell culture models at late timepoints. Olive moments of (A) ES
and ED or (B) NS and ND cell comet assay tails were quantified at different timepoints following sham or
6Gy IR and normalized to the irradiated 0min timepoint to demonstrate apoptotic nuclear fragmentation in
stem cells at late timepoints. N=3. Error bars indicate SEM.
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Figure 2.9. Western blots for apoptotic effectors. ES and ED cells were collected at various
time points following mock or 6Gy irradiation. GAPDH served as a loading control. Clvd casp
3=cleaved caspase-3; Pro casp 3=Pro caspase-3.

2.4.3 Radiation hypersensitivity in stem cells is independent of proliferation status
Since the Law of Bergonié and Tribondeau states that radiosensitivity is strongly correlated with
proliferation rate

23

, we examined whether the observed differential radiosensitivity between stem

and non-stem cells was due to differences in proliferation status. ES and ED cells in culture were
found to proliferate at similar rates as measured by BrdU pulse-chase (Fig 2.10), and Ki67
staining identified both resting and proliferative cells among both the stem and non-stem cell
populations in vivo (Fig. 2.11). Additionally, replicating cells within S phase were detected broadly
throughout and surrounding unirradiated hair follicles by proliferating cell nuclear antigen (PCNA)
staining (Fig. 2.12 A) and BrdU incorporation (Fig. 2.12 B). The relative ratio of proliferative vs.
apoptotic stem cells was then quantified in the SGZ. While only about 30% of stem cells were
proliferative, 75% of stem cells underwent apoptosis (Fig. 2.13 A). Stem cells in vivo were
radiosensitive at low doses, while IR-induced apoptosis was only observed at 8Gy or higher
among non-stem cells of the “proliferative zone” above the intestinal crypt (Fig. 2.2, 2.13 B).
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Terminally differentiated cells were highly radioresistant at all tested doses (Fig. 2.14). These
data indicate that while proliferation status may affect radiosensitivity in non-stem cells, the
hypersensitivity of stem cells to IR is an inherent property of their undifferentiated state.

Figure 2.10. BrdU pulse-chase profiles labeling cell cycle progression of unirradiated stem
and non-stem cells. Timepoints indicate incubation time following removal of BrdU. Rectangles
indicate the presence of G1, S, and G2 populations. 20,000 gated cells were counted for analysis.

Figure 2.11. Proliferation status of stem and non-stem cells in vivo. Immunofluorescence costaining of proliferation marker Ki-67 (red) and stem cell marker SSEA1 (green) in unirradiated tissue
niches. DAPI=DNA. Green arrows indicate stem cells, red arrows indicate proliferative cells. White scale
bar, 10µm.
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Figure 2.12. Proliferating cells exist both within and outside of the hair follicle bulge stem cell
region. Immunofluorescence staining of (A) S-phase marker PCNA (red) and (B) BrdU (green) in
unirradiated skin. DAPI=DNA. White scale bars, 10μm.

Figure 2.13. Apoptosis relative to proliferation status of stem and non-stem cells in
vivo. (A) The fraction of Ki-67 positive (proliferative) or TUNEL positive (apoptotic) cells
among Sox2+ stem cells was quantified across the dentate gyrus at 6h following 6Gy
irradiation. N=3 (combined counting from 7 gyri sections each from 3 separate mice). ** = p <
0.01. (B) Immunofluorescence co-staining of SSEA1 (red) and CC-3, (red) in intestinal crypt
and the proliferative lower villus 12h following 10Gy whole body irradiation. Green and red
arrows indicate cells positive for both stem cell marker and apoptosis marker. DAPI=DNA.
CC-3 = cleaved caspase-3. White scale bar, 10µm.
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Figure 2.14. Model of radiosensitivity relative to proliferation status within the intestinal crypt
and villus. All intestinal crypt stem cells are radiosensitive at low doses, while only proliferative
progenitors of the lower villus display any apoptosis among differentiated cell population.

2.4.4 IR-induced apoptosis of stem cells is more widely distributed throughout the cell
cycle
We also investigated potential differences between stem and non-stem cells in radiosensitivity
across the cell cycle phases. As expected, substantially higher IR-induced apoptosis was
detected in stem cells overall compared to their differentiated progeny (Fig. 2.15). The “apoptotic
ratio” was then quantified throughout each cell cycle phase (Fig. 2.15 inserts) by comparing the
relative percentage of apoptotic cells present in each phase relative to the overall proportion of
the total cell population within that phase. Apoptotic ratios were thus normalized to the overall cell
cycle distribution. Ratios above or below 1.0 indicated increased or reduced propensity to
undergo apoptosis in that phase, respectively. ED cells displayed a strongly increasing apoptotic
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ratio within the G2/M population over time post-irradiation, while in G1 the ratio remained low. In
contrast, ES cells apoptosed across all phases of the cell cycle, displaying a 2-3 times higher
apoptotic ratio in G1 as compared to the ED cells.

Figure 2.15. Differentially distributed radiosensitivity across the cell cycle in stem and
non-stem cells. ES and ED cells were co-stained with FLICA apoptosis marker and propidium
iodide at 8h and 12h after sham or 6Gy IR. The ratio of apoptotic cells (red) relative to total
cells (blue) in each cell cycle phase was calculated to obtain the apoptotic ratio (inserted
graphs). Ratios above or below 1.0 indicate increased or decreased apoptosis, respectively,
within that phase when normalized to the phase distribution of the total cell population.

2.5 DISCUSSION
During radiation therapy patients often suffer from normal tissue injury, limiting the dose that can be used
1

on the tumor. Normal tissue injury as a result of radiation therapy has long been associated with the loss
6

of regenerative stem cell compartments in the affected tissues , resulting in clinical consequences such
24

25

as cognitive impairment , infertility , intestinal epithelial erosion
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4,26

5

and hair loss . Unfortunately, our

understanding of stem cell radiation responses remains incomplete. While several reports suggest high
radiosensitivity of stem cells compared to differentiated cells in the intestine
in ES cells

19,31

27–29

, others have reported relative resistance of stem cells within testis

and brain
22

17,30

as well as

21

and skin . Such

ambiguity may be due to the presence of different stem cell populations within these tissue compartments
32,33

, heterogeneity among tissue types, uncertainty about the true detection/ location of stem cells within

these niches

34

, or potentially even from developmental variation within stem cell compartments .

Moreover, the use of different cell lines as well as prolonged culturing of cells, which possibly influences
35

the cells’ radiation response, might contribute to the heterogeneity between studies . Thus in this study
we chose to analyze early passages of primary stem cells along with multiple in vivo adult stem cell tissue
niches as compared to their isogenic, directly differentiated progeny. We observed stem cell-specific
radiosensitivity in all four analyzed tissue niches and both culture models, suggesting that IR
hypersensitivity is a common phenomenon among different types of stem cells.

Stem cell-specific IR-induced apoptosis is detected in stem cell niches in vivo at 2Gy and above, while
adjacent differentiated cells are radioresistant below 8-10Gy. These observations suggest the likely
existence of a threshold of DNA damage above which cells are unable to repair, as has been previously
36

suggested . This threshold probably exists for various cell types in vivo and is likely defined by the
specifics of a cell’s molecular response to DNA damage. The IR-induced apoptosis-prone phenotype of
stem cells and loss of function of apoptosis upon differentiation was confirmed by clonogenic survival
assay and comet assay. Further, ES cells showed higher expression and activation of pro-apoptotic Bax,
37

in agreement with studies showing constitutively higher levels of Bax in human embryonic stem cells .
ES cells displayed lower expression of anti-apoptotic Bcl-2, which correlates with priming of stem cells to
apoptose in response to DNA damage as has been previously published for human embryonic stem
31

cells .

23

It has long been established that cellular proliferation rate directly correlates with radiosensitivity .
However, highly proliferative tissues may merely elicit the fastest response to radiation and not
38

necessarily the greater overall radiosensitivity . When combined with the predominant use of rapidly
dividing culture models for studying stem cell biology, there remains uncertainty as to whether stem cell
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hypersensitivity is an inherent property of an undifferentiated state or merely a result of rapid proliferation.
Additionally, stem cells vary in their proliferation rates in vivo, as some stem cells are quiescent within
34

their niche while others are proliferating . We studied multiple tissue niches representing varying
proliferation rates and observed that low dose IR-induced apoptosis was exclusive to stem cells
independent of their proliferation status. The highly proliferative non-stem progenitors of the intestinal
crypt underwent low levels of IR-induced apoptosis at higher doses, at which dose terminally
differentiated non-dividing cells stay highly radioresistant. This demonstrates the stark contrast in
radiation responses of cells at varying differentiation states in vivo, in which proliferation state appears
only to affect the radiosensitivity of differentiated cells while stem cells are ubiquitously radiosensitive.
Our findings provide compelling evidence against this established assumption about the true factors
affecting cellular radiosensitivity and should lead to improved understanding of the true basis of stem cell
hypersensitivity.

According to the surviving fraction of cells irradiated in each phase following synchronization, G2/M is
39

typically considered the most radiosensitive phase of the cell cycle followed by G1 and then S phase ,
38

although large variability exists between cell lines . In order to focus on the cell cycle responses to
radiation that contribute to differential IR-induced apoptosis among ES and ED cells, we chose to assess
cell cycle phase radiosensitivity through a unique approach. We investigated whether differences in the
cell cycle arrest of ES and ED cells were associated with a bias in the induction of apoptosis across
different cell cycle phases post-irradiation. By measuring the prevalence of FLICA -positive apoptotic cells
across the cell cycle relative to the total cell cycle distribution, we were able to determine whether there
exists any cell cycle phase bias among the apoptotic population in ES and ED cells. We found that ES
cells maintained apoptotic sensitivity fairly evenly throughout the cell cycle, which could explain stem cells
radiation hypersensitivity, while apoptosis in ED cells was clearly higher towards G2. The hypersensitivity
of stem cells to radiation may be aided by the fact that they remain relatively radiosensitive at all phases
of the cell cycle, while radioresistant differentiated cells in contrast are only radiosensitive during a portion
of the cell cycle. It is known that stem cells fail to activate G1 checkpoint arrest following DNA damage
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40–

42

cells, suggesting a potential connection between the absence of a G1 checkpoint and a more broad

distribution of apoptosis throughout the cell cycle.
This work demonstrates stem cells are hypersensitive to IR both in culture and within multiple tissue
43

niches. We have shown that at therapeutic doses typically used in radiation therapy (2-10Gy) , only
stem cells undergo IR-induced cell death. The clinical side effects from radiation therapy are therefore
not due to loss of the stem cell compartment as a whole, but instead to the individual stem cells within the
niche. By targeting radioprotective therapies and drugs toward radiosensitive stem cells substantial
progress can be made towards minimizing damaging sequelae of radiation therapy, therefore improving
the efficiency and effectiveness of radiation therapy overall.
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CHAPTER 3
Stem Cells Exhibit an Attenuated
DNA Damage Response
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3.1 ABSTRACT
We have previously demonstrated that stem cells are hypersensitive to ionizing radiation (IR) and readily
undergo IR-induced apoptosis while differentiated progeny are quite radioresistant. Here we investigate
whether a uniquely aberrant DNA Damage Response (DDR) in stem cells contributes to this IR
hypersensitivity. Our study determines that stem cells fail to sufficiently activate and maintain DDR
signaling. Despite normal sensing of DNA breaks, recruitment/ retention of repair factors at DNA break
sites is attenuated in stem cells. This attenuated DDR results in diminished DNA repair efficacy and
improper cell cycle checkpoint arrest. Interestingly, while these stem cells are unable to induce γH2AX
foci, during apoptosis they induce pan-nuclear H2AX S139 phosphorylation through the activation of
MST1 and JNK. By investigating this pathway for the first time in stem cells, we provide a potential
mechanism for IR-induced apoptosis independent of DDR signaling. We thus establish that molecular
radiation responses can vary greatly from canonical signaling in specialized cell types such as stem cells,
suggesting that DDR signaling is less ubiquitious than currently believed.

3.2 METHODS
3.2.1 Stem Cell Culture and Differentiation:
Normal embryonic stem (ES) cells were freshly isolated directly from the inner cell mass of
blastocyst stage mouse embryos (E4.5), and later procured from the Washington University
Embryonic Stem Cell Core Facility or ATCC as karyotypically normal early passage ES cells
(EDJ22, RW4). Cells were grown feeder-free on gelatin-coated plates and maintained in high
glucose DMEM with HEPES (Invitrogen) containing 10% Fetal Bovine Serum (Invitrogen), 10%
Newborn Calf Serum (Invitrogen), 0.2% beta-mercaptoethanol (Invitrogen), a nucleoside mix
containing final concentrations of 80μg/ml adenosine, 85μg/ml guanosine, 73μg/ml cytidine,
73μg/ml uridine and 24μg/ml thymidine (Sigma Aldrich) and 10ng/ml LIF (Invitrogen). ES cells
were passaged with 0.05% trypsin containing 0.53mM EDTA (Invitrogen) and selective isolation
of independent colonies from any differentiated cells present. They were differentiated by culture
in the absence of LIF for several days. ES cells were tested bi-monthly for mycoplasma
contamination.
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Neural stem cells were freshly isolated by dissecting the hippocampal region of brains from P0P2 mouse pups and were cultured in suspension after dissociation and trituration in AB2 Basal
Neural Medium (Aruna Biomedical) containing 20ng/ml EGF, 10ng/ml bFGF, 1% N2-Supplement
and 2% B27 (Invitrogen). Neural stem cells were differentiated by addition of 10% FBS (Hyclone)
and removal of EGF/FGF from culture medium upon plating into tissue culture-treated dishes for
attachment.

3.2.2 Animal Models:
Wild-type mouse strain C57BL/6 was used for all in vivo assays unless otherwise noted. Adult 68 week old males were utilized for harvest of brain, intestine, skin and testis for sectioning. For
breeding, 1-6 month old male and female mice of similar age were allowed to mate continuously,
with pregnant females isolated independently before giving birth. P0-P2 mouse pups were
sacrificed by rapid decapitation prior to dissection for neural stem cell isolation. Procedures for all
studies were been approved by the Animal Studies Committee at Washington University Medical
Center.

3.2.3 Antibodies
Details of the antibodies used in this work are described in Table 3.1.

Table 3.1. Antibody Information Table
Protein Target
BrdU (AlexaFluor 488
conjugated)

Species

Company

Catalog #

Assay

Conditions

mouse

Invitrogen

B35139

FACS

Histone H2AX

rabbit

Cell Signaling

#7631

IF, WB

1:20
1:150, 1:2000
in BSA

Ku80

rabbit

Cell Signaling

#2753

IF

1:200

MDC1

mouse

Millipore

05-1572

IF

1:150

MST1

rabbit

Cell Signaling

#3682

IHC-F

1:50

NBS1

rabbit

Abcam

ab32074

IF

1:200

Oct4

rabbit

Abcam

ab19857

IF, IHC-F

1:200, 1:200

PCNA

mouse

Millipore

NA-03

IHC-F

1:100

phospho-ATM (S1981)

mouse

Rockland

200-301-400

IF

1:200
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phospho-ATM (S1981)

mouse

Cell Signaling

#4526

WB, IHC-F

1:500 in milk,
1:50

phospho-ATR (S1989)

rabbit

GeneTex

GTX128145

WB

1:1000 in BSA

phospho-Chk1 (S345)

rabbit

Cell Signaling

#2348

WB

1:1000 in BSA

phospho-DNA-PK (S2056)

rabbit

Abcam

ab18192

IF, IHC-F

1:200, 1:100

phospho-H3 (S10)

mouse

Pierce

MA5-15220

FACS

1:100

phospho-JNK (T183/Y185)

mouse

Santa Cruz

sc-6254

IHC-F, WB

1:50, 1:500

phospho-MST1 (T183)

rabbit

Cell Signaling

#3681

WB

1:1000 in BSA

PLZF

mouse

Santa Cruz

sc-28319

IHC-F

1:50

Rad51

rabbit

Santa Cruz

sc-8349

IHC-F

1:100

Sox2

rabbit

Abcam

ab7959

IHC-F

1:100

Sox2

mouse

Abcam

ab79351

IF, IHC-F

1:200, 1:100

SSEA1

mouse

Abcam

ab16285

IHC-F

1:100

Total ATM

rabbit

Cell Signaling

#2873

WB

1:1000 in BSA

Total ATR

rabbit

Cell Signaling

#2790

WB

1:500 in milk

Total Chk1

mouse

Cell Signaling

#2360

WB

γH2AX (S139)

mouse

Millipore

05-636

WB, IHC-F

1: 1000 in milk
1:4000 in
BSA, 1:400

γH2AX (S139)

rabbit

Cell Signaling

#7631

IHC-F

GAPDH
FITC-conjugated antirabbit
FITC-conjugated antimouse
AMCA-conjugated antimouse
AMCA-conjugated antirabbit
Texas Red-conjugated
anti-mouse
Texas Red-conjugated
anti-rabbit
HRP-conjugated antimouse
HRP-conjugated antirabbit

mouse

Sigma Aldrich

G8795

WB

1:150
1:100,000 in
milk

donkey

Vector

FI-1000

IF, IHC-F

1:100

horse

Vector

FI-2000

IF, IHC-F

1:100

horse

Vector

CI-2000

IF

1:75

donkey

Vector

CI-1000

IF

1:75

horse

Vector

TI-2000

IF, IHC-F

1:100

donkey

Vector

TI-1000

IF, IHC-F

1:100

rabbit

Sigma Aldrich

A9044

WB

1:5000 in milk

goat

Sigma Aldrich

A0545

WB

1:5000 in milk

3.2.4 X-Ray Irradiation and Tissue Sectioning:
Cells and animals were irradiated in the RS-2000 Biological Research Irradiator (Rad-Source) at
room temperature, with mock/control irradiated samples brought into the room to simulate the
reduction in ambient temperature and account for any stress imparted by the travel. Cells were
always placed within the central circle directly under the x-ray source to maintain consistency in
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dose between samples. Animals were anesthetized with isofluorane and placed on their back in
the machine for whole-body irradiation to properly expose all tissues of interest to the x-ray
source. Accuracy of all doses was confirmed by dosimeter probe. Both cells and animals were
randomly assigned to individual timepoints or sham-irradiation controls.

Following irradiation, mice were sacrificed at specific timepoints by CO 2 asphyxiation and cervical
dislocation. Organs were harvested, placed in OCT media and frozen in liquid nitrogen. Frozen
tissues were sectioned on a cryostat machine at a thickness of 10μm, placed onto adhesive
o

slides and stored at -80 C.

3.2.5 Western Blotting:
Cellular protein lysates were collected in RIPA buffer, electrophoresed on 4-15% Tris-Glycine
o

polyacrylamide gels (BioRad), transferred onto PVDF membranes and incubated overnight at 4 C
with various primary antibodies followed by washing and secondary antibody incubation for 2hr at
room temperature. Super ECL (GE/Pierce) was used as substrate for detection on
autoradiography film or ChemiDoc MP digital system (BioRad).

3.2.6 Immunofluorescence:
Freshly frozen tissues were isolated from testis, brain, intestine and skin following 6Gy irradiation
or 0Gy mock before embedding in OCT media and sectioning onto slides. Slides of tissue
sections or coverslips of cells were fixed in 4% formaldehyde and permeabolized with 0.2%
Triton-X followed by blocking with 2% BSA. Tissues were incubated with primary antibodies in 1%
o

BSA at 37 C for 3hr, washed and then incubated with secondary fluorescently-tagged secondary
o

antibodies for 45min at 37 C. Tissues were then mounted in place with coverslips containing
mounting media with DAPI (Vector) for identification of nuclei.

Cells were similarly fixed in 4% formaldehyde and permeabilized with 0.2% Triton-X before
o

blocking. For double-color staining, primary antibodies were incubated together for 1hr at 37 C
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followed by wash and incubation with fluorescently-tagged secondary antibodies for 30min at
o

37 C. For triple-color staining, following the original staining procedure, cells were incubated with
o

o

1:1000 α-γH2AX antibody for 15min at 37 C followed by 12min incubation at 37 C with the
appropriate secondary antibody. Anti γH2AX antibody was chosen to match Sox2 to avoid crossreaction with the other target antigen of interest.

3.2.7 Neutral Comet Assay:
To assess repair of DNA double strand breaks, neutral comet assays were performed using
CometSlide assay kits (Trevigen). Cells were collected at multiple timepoints following 6 Gy
irradiation or 0 Gy mock and embedded in agarose on slides at equal concentrations. Slides were
electrophoresed in TAE buffer, fluorescently stained with SYBR Green (Trevigen), and visualized
by fluorescent microscopy. Olive comet moment was calculated using the CometScore software
(TriTek) to analyze 50-100 comets per sample, with each series of timepoints repeated at least
three independent times as both biological and technical replicates. Individual comets were
randomly selected for scoring from similar regions of the slide in all samples. Outliers were
eliminated that fell greater than 1.5 standard deviations from the mean. Standard error was
calculated for each cell type and timepoint normalized to the value of the 0min samples, while the
significance of the difference between cell types over time was analyzed by Analysis of
Covariance (ANCOVA) using XLStat statistical software (Addinsoft), with two-sided significance
set at p<0.05. Data from all samples was approximately normally distributed, and the standard
deviation between samples within the same experiment was similar. Samples were excluded
from analysis only due to technical errors from the assay or cells being visibly unhealthy.

3.2.8 Laser Microirradiation
Stem cells (ES, NS) were co-plated with non-stem cells (ED, MEF) on glass coverslips and
incubated for 2 days with 30μM BrdU (Sigma Aldrich) to sensitize DNA for DSB induction. Prior
to laser microirradiation, cells were incubated with Stem Cell cDy1 Dye (Active Motif) for 30min to
fluorescently label live stem cells for identification. Coverslips were then placed in circular
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magnetic chambers (Quorum Technologies) with media to be properly aligned for
microirradiation. Cells were microirradiated in a defined narrow region across adjacent stem and
non-stem cells with 8000-12000 iterations of 405+633nm laser on the LSM 510 Confocal
Microscope (Zeiss) at 45% power output. Care was taken to include stem (cDy1 positive) as well
as non-stem cells in the DNA damage tracks. Cells were microirradiated for 20-30min per sample
unless otherwise stated, with 6-12 regions of microirradiation per sample.

3.2.9 Cell Cycle Analysis
For cell cycle profiling, cells were isolated at various timepoints following irradiation and ethanolo

fixed overnight at -20 C. Ethanol-fixed cells were washed and incubated with RNase for 30min at
o

37 C for 30min before staining with propidium iodide and analyzing by flow cytometry.

ES and ED cells were incubated with 20μM BrdU (Sigma) for 30min, irradiated, washed 2 times
and chased for various timepoints to allow cell cycle progression. Cells were then fixed overnight
o

in ethanol at -20 C, incubated with RNase and propidium iodide, and analyzed by flow cytometry.

For G2/M checkpoint arrest, cells were first ethanol-fixed at various timepoints following sham or
6Gy irradiation. Cells were then washed, blocked in 2% BSA and incubated for 1h with phosphoo

histone H3 (S10) antibody at 37 C to label mitotic cells. Following washes, cells were incubated
o

with 1:100 FITC-conjugated anti-mouse 2 antibody for 30min at room temperature. Following
another wash cells were incubated with RNase and propidium iodide as before and analyzed by
flow cytometry. G2/M arrest was indicated by decrease in the percentage of mitotic cells.

3.2.10 Cytogenetic Analysis
Cells were incubated with 100ng/ml colcemid for 2-4hrs following 6Gy irradiation or 0Gy mock to
arrest cells in metaphase. Mitotic cells were selectively isolated by mitotic shake-off, incubated in
hypotonic buffer (0.56% KCl) for 8 min, fixed in acetate-methanol and dropped onto slides.
Fluorescent in situ hybridization was performed using oligonucleotide (TTAGGG) 3 PNA probes
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using standard protocols and counterstained with DAPI. Chromosomes were then visualized by
fluorescence microscopy and scored for chromosome aberrations. The number of chromosome
aberrations was normally distributed for each sample, with similar standard deviations between
samples from the same time point. Each sample was repeated three times. Chromosome
aberrations were defined as chromosome or chromatid breaks, translocations, or radials.
Standard error was calculated and statistical significance was determined by Student’s t-test, with
two-sided significance set at p<0.05. Only full chromosome plates were scored, any partial plates
were excluded from scoring.

3.2.11 Microscopy and Image Processing
Micrographs were captured utilizing MetaSystems ISIS imaging software on Zeiss Axioplan2
microscope or ZEN software on Zeiss LSM510 confocal microscope with the 20x, 63x or 100x
objective lenses. Minimal threshold and contrast manipulation was performed equally across
entire images. Controls were processed equally with treated samples. Adobe Photoshop CS3
software was utilized for composing the collages of multiple pictures and labeling micrographs
and Immunoblots in individual layers.

3.2.12 Statistical Analysis
A ‘two-tailed’ Student's t-test was used to calculate the statistical significance of the observed
differences. In all cases, differences were considered statistically significant when p<0.05.
Unless otherwise indicated, values represent mean ± SEM.

3.3 INTRODUCTION
Radiation therapy utilizes ionizing radiation (IR) to produce lethal DNA double-strand breaks (DSBs) in
cancer cells; however detrimental sequelae often result from unintended damage to normal tissue. Work
from previous chapters elucidated that these consequences are likely due to the loss of stem cells from
the affected tissue niche, as IR induces apoptosis only in stem cells while differentiated cells are
radioresistant. Having established that stem cells are hypersensitive to IR both in vivo and in culture, we
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examined the molecular mechanisms responsible for this differential radiosensitivity among stem and
differentiated cells. An improved understanding of cellular radiation responses is essential for the
development of strategies to protect normal tissue during radiotherapy.

1

Aberrant DNA damage response (DDR) signaling often leads to genomic instability and cell death ,
suggesting that inadequate DDR signaling and DNA repair may contribute to radiation hypersensitivity.
The DDR is an intricate network of molecular signaling following DSBs that enables proper damage
sensing, recruitment of repair factors and subsequently DNA repair. In mammals, the Mre11–Rad50–
Nbs1 (MRN) complex initially senses DNA breaks

2,3

. This is followed by activation of phosphatidylinositol

3-kinase-related kinases (PIKKs), which include ataxia telangiectasia mutated (ATM), ATM and Rad3related (ATR), and DNA-dependent protein kinase catalytic subunit (DNA-PKcs). Activated ATM
phosphorylates histone H2AX on serine 139, marking mega-bases of chromatin around the DSB with
γH2AX

4,5

6

, and serving as a docking site for downstream repair factors . Following repair factor assembly

and cell cycle checkpoint activation, the DDR initiates DNA DSB repair. In the absence of efficient repair,
1

apoptosis may be induced to eliminate cells with compromised genomic integrity .

Here we establish that stem cells across multiple tissue niches and culture models exhibit a severely
attenuated DDR, demonstrating reduced activation and recruitment of various DDR and DNA repair
factors following irradiation. We also show that stem cells demonstrate limited DNA repair and insufficient
cell cycle checkpoint arrest, resulting in DDR-independent apoptosis through the MST1-JNK-H2AX
pathway. By elucidating that stem cell radiosensitivity is associated with an abrogated DDR and
inadequate DNA repair capacity, this work identifies potential molecular targets for radioprotecting stem
cells to improve patient outcomes following radiation therapy.

3.4 RESULTS
3.4.1Stem cells exhibit an attenuated DDR
We utilized tissue sections isolated from brain, testis, intestine and skin in order to delineate
whether any differences in the DDR among stem and non-stem cells in vivo was associated with
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their previously observed differential radiosensitivity. We observed a remarkable absence of
γH2AX foci from individually labeled stem cells in all tissues surveyed shortly following irradiation,
while adjacent non-stem cells displayed robust IR-induced foci (IRIF) formation (Fig. 3.1)
compared to unirradiated controls (Fig 3.2). We then utilized subnuclear laser microirradiation in
order to observe recruitment of DDR factors to defined regions of DNA damage in culture. Stem
cells in culture also exhibited strongly attenuated IR-induction of γH2AX both along
microirradiation-induced DSBs (Fig. 3.3 A-B) and globally (Fig. 3.4 A) compared to equivalentlytreated non-stem cells. Total H2AX levels were similar among the cell types and remained
unchanged following irradiation (Fig. 3.4 A-B). H2AX S139 is phosphorylated primarily by
4,5

activated ATM kinase . We therefore investigated whether repressed ATM activation is
responsible for the abrogation of γH2AX formation in stem cells. Immunoblots showed markedly
reduced activation of ATM by phosphorylation of serine 1981 (pATM) in stem cells without any
reduction in total ATM levels (Fig. 3.5). ATM activation can also occur independently of its
7

recruitment to DNA damage , hence we assessed the recruitment of pATM to DSBs. Subnuclear
microirradiation confirmed the inability of stem cells to adequately activate and recruit pATM to
DNA breaks, while in contrast co-plated and co-treated non-stem cells displayed robust
recruitment of pATM to the damaged region (Fig. 3.6). Complete abrogation of ATM activation
and recruitment was also observed in vivo following irradiation (Fig. 3.7 A-B). Immunoblotting of
stem cells in culture also demonstrated reduced ATR activation as indicated by both decreased
8

phosphorylation of the DNA damage-responsive serine 1989 site and diminished activation of
the ATR substrate checkpoint kinase 1 (Chk1) (Fig. 3.8).

Stem cells failed to recruit activated non-homologous end joining (NHEJ) repair factor DNA-PKcs
9

(pDNA-PKcs) phosphorylated at serine 2056 both in culture (Fig. 3.9 A) and in vivo within the
SGZ (Fig. 3.9 B). Rad51 foci indicating homologous recombination (HR) repair were also not
detected in stem cells in vivo within irradiated testis and intestine (Fig. 3.10 A-B). Despite the
presence of actively proliferating stem cells in vivo (Fig. 2.11), only proliferating differentiated
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cells displayed Rad51 foci. Together these data clearly demonstrate that stem cells exhibit
severely abrogated induction and recruitment of DDR factors in response to IR.

Figure 3.1. Absence of γH2AX IRIF in stem cells in vivo. Immunofluorescence co-staining of stem cell
markers (red; Sox2, SSEA1, Oct4) and γH2AX (green) in tissue niches 15min following 6Gy IR.
DAPI=DNA. Arrows indicate stem cells in vivo lacking γH2AX IRIF.
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Figure 3.2. Sham-irradiated negative controls for in vivo γH2AX IRIF. Immunofluorescence costaining of stem cell markers (red, Sox2, Oct4) and γH2AX (green) in tissue niches following sham
irradiation.

Figure 3.3. γH2AX induction is attenuated along DSBs in cultured stem cells. Immunofluorescence
co-staining of (A) Sox2 (green) and γH2AX (red) on co-plated ES and ED cells, DAPI=DNA, or (B) Sox2
(blue) and γH2AX (red) on co-plated NS and ND cells 30min following microirradiation. DAPI=DNA.
γH2AX was substantially attenuated in approximately 70% of laser tracks. White scale bars, 10µm.
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Figure 3.4. Global attenuation of IR-induced γH2AX in cultured stem cells is not due to reduced
H2AX expression. (A) Western blots for γH2AX and histone H2AX at various time points following
mock or 6Gy irradiation of ES and ED cells. GAPDH served as a loading control. (B)
Immunofluorescence co-staining of Sox2 (blue) and histone H2AX (red) on co-plated unirradiated ES
and ED cells. White scale bars, 10μm.

Figure 3.5. IR-induced ATM activation is attenuated in cultured stem cells. Western blots for
pATM and total ATM at various time points following mock or 6Gy irradiation of ES and ED cells.
GAPDH served as a loading control.
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Figure 3.6. pATM is not recruited to DSBs in cultured stem cells. Immunofluorescence costaining of Sox2 (blue) and pATM (green) on co-plated ES and ED cells following
microirradiation. White scale bars, 10µm.

Figure 3.7. IR-induced activation and recruitment of ATM IRIF is attenuated in stem cells in vivo.
Immunofluorescence co-staining of Sox2 (red) and pATM (green) in brain 15min following (A) sham or (B)
6Gy IR. DAPI=DNA. White scale bars, 10µm.
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Figure 3.8. IR-induced ATR activation is attenuated in cultured stem cells. Western blots for
pATR, total ATR, pChk1 and total Chk1 on ES and ED cells at various time points following mock or
6Gy irradiation of ES and ED cells. GAPDH served as a loading control.

Figure 3.9. Recruitment of pDNA-PKcs to DSBs is attenuated in stem cells both in culture
and in vivo. (A) Immunofluorescence co-staining of Sox2 (blue), γH2AX (red) and pDNA-PKcs
(green) on co-plated ES and ED cells following microirradiation. (B) Immunofluorescence costaining of Sox2 (red) and pDNA-PK (green) in brain 4h following sham or 6Gy IR. DAPI=DNA.
White scale bars, 10μm.
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Figure 3.10. Rad51 recruitment to IRIF is attenuated in stem cells in vivo. Immunofluorescence costaining of (A) PLZF (red) and Rad51 (green) in testis and (B) Rad51 (green) alone in intestine 4h
following sham or 6Gy IR. DAPI=DNA. White scale bars, 10µm.

3.4.2 Stem cells display impaired cell cycle arrest compared to differentiated cells
To examine whether a difference in cell cycle control could be connected to the increased
apoptosis in stem cells, the cell cycle distributions of ES and ED were analyzed after IR.
Beginning at 2 h and maximizing at 6-8 h, IR induced the accumulation of cells in G2 in both ES
and ED cells (Fig. 3.11). In agreement with our previous experiments, only ES cells displayed a
strong induction of a subG1 population representing the apoptotic fragmentation of DNA.
Additionally, in ES cells IR induced a greater shift in the ratio towards G2, while they show almost
a complete absence of G1 accumulation. In contrast, ED cells maintained a substantial G1
population at all time points. Moreover, pulse-chase of BrdU-labeled ES and ED cells up to 8h
after irradiation confirmed the lack of G1 accumulation in stem cells (Fig. 3.12). These results
suggest an absence of G1 arrest in ES cells, unlike their isogenic differentiated cells. G2/M
checkpoint arrest has previously been observed in ES cells

10,11

, however the details of G2/M

arrest has not been compared between stem and differentiated cells. In order to assess both the
initiation and maintenance of G2/M arrest, we quantified the percentage of cells staining positive
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for the mitosis marker histone H3 serine 10 phosphorylation at multiple timepoints following
irradiation. Our results showed that both stem and non-stem cells demonstrate a rapid G2/M
arrest as indicated by the decrease in mitotic cells within 1h of irradiation. Contrary to
differentiated cells however, ES cells were unable to fully block mitotic entry and were completely
released from G2/M arrest by 9h post-irradiation (Fig. 3.13). ED cells are able to completely block
cell cycle progression into mitosis and in contrast show sustained maintenance of G2/M arrest up
to 12h following irradiation. Weaker cell cycle checkpoint controls in stem cells may serve as an
additional contributing mechanism toward their enhanced radiosensitivity.

Figure 3.11. Cell cycle profile overlays of irradiated stem and non-stem cells. Cell cycle
profiles of ES and ED cells were collected at multiple timepoints following sham or 4Gy IR. Blue
outline, ES; red outline, ED. 10,000 gated cells were counted for analysis.
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Figure 3.12. BrdU pulse-chase profiles of irradiated stem and non-stem cells. ES and ED
cells were labeled with BrdU and chased for multiple timepoints following sham or 4Gy IR.
Rectangles indicate the presence of G1, S, and G2 populations. Solid rectangle, G1 population;
dotted rectangle, absence of G1 population. 20,000 gated cells were counted for analysis.

81

3.00

% Mitotic Cells

2.50

2.40%
2.20%

2.00

2.33%

1.82%

1.50

ES
1.20%

1.00

0.75%
0.74%

0.50
0.00

ED

0.21%
0.10%

0

2

0.58%
0.21%
0.02%

4

6

8

10

Time (hrs)
Figure 3.13. Stem cells exhibit a shortened G2 checkpoint arrest. ES and ED cells were collected at
multiple timepoints following sham or 6Gy irradiation and mitotic cells were labeled with phospho-histone
H3 (S10). G2/M arrest was measured by observed reduction in the percentage of mitotic cells in the
population.

3.4.3 Stem cells fail to adequately repair DSBs
Differences in DNA repair proficiencies between stem and non-stem cells in culture were then
quantified. The non-stem cells exhibited efficient repair as indicated by rapid reduction of DNA
breaks within 1h of irradiation (Fig. 3.14). Stem cells in contrast exhibited significantly diminished
repair efficiency, paralleling the repair kinetics of H2AX -/- cells

12

. Stem cells ultimately failed to

show substantial DNA repair until 4h post-IR, when many of the radiosensitive cells had already
begun dying and dropping out of the population (Fig. 2.9). Stem cells also displayed significantly
higher incidences of unrepaired chromosome/chromatid breaks and fragmented/blebbing nuclei
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following IR, while only minimal aberrations were seen in unirradiated controls (Fig. 3.15 A-B,
3.16). Despite attenuated DDR signaling, we did observe recruitment of the MRN complex protein
Nibrin (NBS1) to microirradiation tracks in stem cells (Fig. 3.17) along with Ku80 (Fig. 3.18),
another early responder to DSBs as part of the Ku70/80 heterodimer

13

. The presence of these

factors may enable the observed low level of basal repair (Fig. 3.14). Inhibition of the DDR in
stem cells thus leads to reduced DNA repair efficiency and likely relates to their reduced
threshold for DNA damage-induced apoptosis.

Figure 3.14. Neutral comet assay on stem and non-stem cells to measure DNA repair. Olive
moments of NS and ND cell comet assay tails were quantified at different timepoints following
sham or 6Gy IR and normalized to the irradiated 0min timepoint in order to measure DNA repair
over time. The difference in olive moment across the entire timecourse was significant by
ANCOVA, p = 0.013; N=3. Error bars indicate SEM.
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Figure 3.15. Chromosome preparations from stem and non-stem cells. (A) Metaphase chromosomes
isolated from unirradiated ES, ED, NS and ND cells. (B) Metaphase chromosomes and fragmented nuclei
isolated from ES, ED, NS and ND cells following 6Gy IR. Red, telomere; DAPI=DNA. Arrowheads indicate
clusters of chromosome aberrations.

Figure 3.16. Cultured stem cells show more residual chromosomal aberrations than non-stem
cells following irradiation. Chromosome aberrations were quantified in stem and non-stem cells
following 2Gy or sham irradiation. N=3; **, p < 0.01. Aberrations were scored as the sum of
chromosome/chromatid breaks, translocations, and radials. Error bars indicate SEM.
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Figure 3.17. MRN complex is recruited to

Figure 3.18. Ku complex is recruited to

DSBs in cultured stem cells.

DSBs in cultured stem cells.

Immunofluorescence co-staining of Sox2

Immunofluorescence co-staining of Sox2

(blue), γH2AX (red) and NBS1 (green) on

(blue), γH2AX (red) and Ku80 (green) on co-

co-plated ES and ED cells following

plated ES and ED cells following

microirradiation. Arrowhead indicates the

microirradiation. Arrowhead indicates the

presence of NBS1 despite attenuated

presence of Ku80 despite attenuated

induction of γH2AX. White scale bar, 10µm.

induction of γH2AX. Individual ES and ED
pictures shown were irradiated together
following co-plating. White scale bar, 10µm.
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3.4.4 IR-induced apoptosis in stem cells involves MST1-JNK-H2AX pathway
While IR-induced apoptosis typically involves DDR signaling through ATM and p53

14

, stem cells

underwent IR-induced apoptosis despite deficiencies in DDR signaling and DNA damage-induced
apoptosis in stem cells has been shown to be p53-independent

15

. The ability of stem cells to

apoptose despite the absence of DDR components was confirmed by observing apoptosis in the
stem cell regions of DDR factor-deficient mice (Fig. 3.19). We therefore investigated potential
alternative apoptotic pathways that could be active in stem cells. Once activated by caspase
cleavage

16

, autophosphorylation

17

and subsequent nuclear translocation, mammalian Ste20-like

kinase (MST1) pan-phosphorylates H2AX-S139 in addition to activating c-Jun N-terminal kinase
18

(JNK) , which can in turn also pan-phosphorylate H2AX-S139

19

. Despite the absence of γH2AX

IRIF in stem cells (Fig. 3.1, 3.3), by 6h post-irradiation they induced pan-nuclear H2AX S139
phosphorylation (H2AX-pS139) (Fig. 3.20 A-B). MST1 was phosphorylated only in stem cells
following irradiation (Fig. 3.21), and pan-nuclear H2AX-pS139 signals colocalized with nuclear
translocation of otherwise cytoplasmic MST1 in the SGZ at late timepoints (Fig. 3.22).
Additionally, JNK was found to be activated through its phosphorylation (pJNK) only in stem cells
at these late timepoints following irradiation both in culture (Fig. 3.21) and in vivo (Fig. 3.23 A-B).
pJNK also co-stained with pan-nuclear H2AX-pS139 (Fig. 3.24) in the SGZ stem cell region. IRinduced apoptosis in stem cells therefore does not require DDR components and signals through
the MST-JNK-H2AX pathway.
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Figure 3.19. Apoptosis in stem cell regions in vivo does not require DDR components.
Immunofluorescence staining of cleaved poly (ADP-ribose) polymerase (PARP) in H2AX -/-, SCID,
and ATM -/- brain 6h following 6Gy IR. DAPI=DNA. White scale bars, 10µm.

Figure 3.20. Stem cells in vivo induce pan-nuclear H2AX-pS139 at late timepoints following
irradiation. (A) Immunofluorescence co-staining of Sox2 (red) and pan-nuclear H2AX-pS139 (green) in
brain 6h following 6Gy IR. (B) Immunofluorescence staining of pan-nuclear H2AX-pS139 (green) in
tissue niches 6h following 6Gy IR. Arrows indicate apoptotic H2AX-pS139 in stem cell regions.
DAPI=DNA. White scale bars, 10µm.
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Figure 3.21. MST1 and JNK are activated only in cultured stem cells at late timepoints
following irradiation. Western blots for pMST1 at various time points following mock or
6Gy irradiation of NS and ND cells along with western blots for pJNK at various time points
following mock or 6Gy irradiation of ES and ED cells. GAPDH served as a loading control.

Figure 3.22. MST1 is nuclear translocated correlating with the onset of H2AX-pS139 in
stem cell regions. Immunofluorescence co-staining of MST1 (red) and pan-nuclear H2AXpS139 (green) in brain 15min, 1h and 6h following 6Gy IR. DAPI=DNA. White scale bars, 10μm.
88

Figure 3.23. pJNK is activated in stem cells in vivo at late timepoints following irradiation.
Immunofluorescence co-staining of (A) pJNK (green) and Sox2 (red) in brain and (B) pJNK (green) and Oct4
(red) in testis 6h following either sham or 6Gy IR. DAPI=DNA. White scale bars, 10μm.

Figure 3.24. pJNK colocalizes with H2AX-pS139 in stem cell regions. Immunofluorescence costaining of pJNK (red) and pan-nuclear H2AX-pS139 (green) in brain 6h following 6Gy IR. DAPI=DNA.
White scale bar, 10μm.
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3.5 DISCUSSION
This work demonstrates that normal stem cells in vivo as well as in culture exhibit an aberrant DDR and
are deficient in repairing DNA DSBs compared with their isogenic differentiated non-stem progeny. Our
most striking finding is the austere lack of IRIFs in stem cells, including pATM and γH2AX. Stem cells
therefore appear to be unique in their inability to activate the DDR, demonstrating stark heterogeneity in
the molecular responses to DNA damage among cells of varying differentiation status. This suggests that
not all cells respond similarly to DNA damage, challenging existing assumptions about the ubiquitous
nature of the DDR and its generalizability to all cell types.

While stem cells are unable to induce IRIFs, they are able to sense DNA breaks through the recruitment
of Nbs1 and Ku80, in agreement with previous studies demonstrating that MRN recruitment does not
require H2AX or its phosphorylation
independent of H2AX

20–22

. The MRN complex is sufficient for promoting DNA repair

22,23

, which may explain how stem cells are able to repair endogenous physiological

levels of damage despite an attenuated DDR. The kinetics of DSB repair in stem cells are similar to H2AX
12

-/- murine embryonic fibroblasts , further indicating that stem cells are essentially a naturally-occurring
DDR-null cell type. This similarity also causally links their attenuated DDR and muted DNA repair.
Additionally, the radiosensitivity of ATM and H2AX-deficient cells has been attributed to their DSB repair
defects

24,25

, suggesting that the inhibited DDR signaling and DSB repair capacity of stem cells may

directly influence their radiosensitivity.

There are conflicting reports on the relative efficiency of cultured stem cells in repairing DNA damage
and DDR activation in stem cells has also been observed by several groups

26–31

11,32–34

. However, many of

these studies did not emphasize the use of early passage, primary cultures or isogenic direct
differentiation as our study does, and prolonged passage of stem cells in culture results in epigenomic
changes

35

that lead to modified radiation responses [unpublished observations]. Additionally, mouse and
36

human ES cells appear to differ in their radiation responses . In agreement with our studies, murine ES
cells (albeit not human ES cells) have been reported as deficient in repairing DNA breaks

36

and murine

induced pluripotent stem cells have recently been found to exhibit inadequate H2AX phosphorylation and
90

,

37

DNA repair . Unirradiated ES cell lines have been found to exhibit high basal γH2AX levels that are
38

believed to be important for self-renewal , but this basal γH2AX appears to be independent of DDR
39

signaling . These discrepancies also reinforce the significance of corroborating work with in vivo tissue
niches when possible, as was done in our study.

Studies on intestinal crypts

40,41

have observed the presence of IRIFs in stem cells but also demonstrated

IR-induced cell death in those same cells. Stem cells within the hair follicle have been shown to
42

sufficiently activate the DDR , however it appears that the hair follicle may contain distinct stem cell
populations

43

with varying biological radiation responses. Our observations in testicular stem cells agree

with previous studies showing abrogated γH2AX induction following IR

44

(however again with

contradictory radiosensitivity data).Variability among this data is likely due to the presence of different
stem cell populations within these niches as well as developmental heterogeneity related to the continual
turnover of each tissue compartment. All of our work on brain stem cells is novel, as radiation responses
in brain have only been previously studied in a developmental context without the use of specific stem cell
markers

45,46

.

While ED cells appear to arrest at both G1 and G2 checkpoints after irradiation, ES cells accumulate in
G2, suggesting a lack of G1 checkpoint activation and subsequent arrest. This result agrees with existing
reports suggesting that stem cells lack a functional G1 checkpoint
48

nonfunctional p21 pathway

11,15,47

, which is in part due to both a

49

and improper Chk2 localization . Restoration of the G1 checkpoint has

been shown to significantly reduce IR-induced apoptosis

50,51

, supporting the idea that an absent G1

checkpoint may contribute to stem cell hypersensitivity. The length of IR-induced G2 arrest among cells
typically correlates with cell cycle time

52

. ES cells do not have a substantially longer cell cycle than ED

cells however, yet employ a unique cell cycle response to radiation. ES cells rapidly activated IR-induced
G2/M arrest similar to ED cells, however ED cells showed a much more gradual release from arrest. This
shortened length of G2/M arrest in stem cells is likely due to their reduced activation of ATR and Chk1
10,53,54

. We also cannot ignore the possibility that by later timepoints many radiosensitive stem cells may

have already died, whereby the observed restoration of the basal mitotic ratio merely represents an
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artifact of the remaining survivor population. Interestingly, while the length of G2/M entry delay among
different cell types following DNA damage-induced S-phase arrest may directly correlate with
55

56

radiosensitivity , the relationship between G2/M arrest and radiosensitivity is less clear . Nonetheless,
reduced length of G2/M arrest in stem cells may hamper proper completion of DNA repair and limited
evidence does correlate reduced G2/M arrest with radiosensitivity, especially in cells already lacking G1
arrest

57,58

.

We observed apoptotic signaling through the JNK-MST1-H2AX pathway only in stem cells both in culture
and in vivo. While MST1 activation was a downstream result of apoptosis signaling, evidence suggests
59

that it may also directly promote apoptosis by blocking Bcl-xL . MST1-mediated H2AX panphosphorylation at S139 is required for completion of apoptosis through DNA fragmentation

16,19

. Our work

suggests that stem cells do not require DDR signaling for apoptosis, in agreement with another report
which found that ATM deficiency only prevented IR-induced apoptosis in differentiated neuronal cells
while stem cells remained radiosensitive

60

. The JNK-MST1-H2AX pathway may represent an alternative

mechanism for IR-induced apoptosis in the absence of DDR signaling. The observation of apoptosis in
H2AX -/- cells suggests that other pathways may also be active in stem cells, however H2AX-pS139 is
only involved in the final “clean-up” stages of apoptosis

19

so upstream signaling would not be affected. It

is interesting that apoptotic pan-nuclear phosphorylation of S139 occurs in stem cells, despite abrogated
γH2AX (ATM-mediated S139 phosphorylation around DNA break sites) immediately following DNA
damage. We submit that chromatin changes induced by the onset of apoptosis may allow access to the
break site and thus enable pan-nuclear S139 phosphorylation.

One may wonder how stem cells would have developed such a radiosensitive phenotype. While the
decision by stem cells to undergo apoptosis in response to IR in lieu of repairing the DNA damage may
be an adaptive response, wherein the long-term genomic integrity of the lineage is protected by removing
damaged stem cells, these radiation responses may also be merely a coincidence of their distinctive
chromatin environment and epigenetic profile. Regardless, these findings provide novel insights in the
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fields of DDR and normal stem cell biology, while also identifying potential new molecular targets for
preventing stem cell depletion associated with radiotherapy.
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CHAPTER 4
Unique Epigenetic Regulation Contributes to
Stem Cell Radiosensitivity
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4.1 ABSTRACT
Our work has shown that stem cells are uniquely hypersensitive to IR, readily undergoing IR-induced
apoptosis and failing to sufficiently activate DNA repair signaling pathways. Stem cells exhibit an
attenuated DNA Damage Response (DDR), which leads to diminished DNA repair capacity and DDRindependent apoptosis. Various histone modifications have been implicated as playing an important role
in the molecular responses to DNA damage. Since stem cell pluripotency is controlled by several uniquely
regulated histone modifications, we investigated whether the distinctive epigenetic environment of stem
cells could contribute to their radiosensitivity and abrogated DDR. We found that IR-induced apoptosis in
stem cells corresponds to the persistence of H2AX-Y142 phosphorylation around break sites, which
promotes apoptosis through JNK while inhibiting DDR signaling. The abrogated DDR in stem cells is also
associated with constitutively elevated histone-3 lysine-56 acetylation, which may hinder retention of
repair factors and directly contributes to stem cell radiosensitivity. These data establish that unique
epigenetic landscapes among differing cell types can impart heterogeneity in the DDR, resulting in
varying radiosensitivities.

4.2 METHODS
4.2.1 Stem Cell Culture and Differentiation:
Normal embryonic stem (ES) cells were freshly isolated directly from the inner cell mass of
blastocyst stage mouse embryos (E4.5), and later procured from the Washington University
Embryonic Stem Cell Core Facility or ATCC as karyotypically normal early passage ES cells
(EDJ22, RW4). Cells were grown feeder-free on gelatin-coated plates and maintained in high
glucose DMEM with HEPES (Invitrogen) containing 10% Fetal Bovine Serum (Invitrogen), 10%
Newborn Calf Serum (Invitrogen), 0.2% beta-mercaptoethanol (Invitrogen), a nucleoside mix
containing final concentrations of 80μg/ml adenosine, 85μg/ml guanosine, 73μg/ml cytidine,
73μg/ml uridine and 24μg/ml thymidine (Sigma Aldrich) and 10ng/ml LIF (Invitrogen). ES cells
were passaged with 0.05% trypsin containing 0.53mM EDTA (Invitrogen) and selective isolation
of independent colonies from any differentiated cells present. They were differentiated by culture
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in the absence of LIF for several days. ES cells were tested bi-monthly for mycoplasma
contamination.

Neural stem cells were freshly isolated by dissecting the hippocampal region of brains from P0P2 mouse pups and were cultured in suspension after dissociation and trituration in AB2 Basal
Neural Medium (Aruna Biomedical) containing 20ng/ml EGF, 10ng/ml bFGF, 1% N2-Supplement
and 2% B27 (Invitrogen). Neural stem cells were differentiated by addition of 10% FBS (Hyclone)
and removal of EGF/FGF from culture medium upon plating into tissue culture-treated dishes for
attachment.

4.2.2 Animal Models:
Mouse strain C57BL/6 was used for all animal studies. Adult 6-8 week old males were utilized for
harvest of brain, intestine, skin and testis for sectioning. For breeding, 1-6 month old male and
female mice of similar age were allowed to mate continuously, with pregnant females isolated
independently before giving birth. P0-P2 mouse pups were sacrificed by rapid decapitation prior
to dissection for neural stem cell isolation. Procedures for all studies were been approved by the
Animal Studies Committee at Washington University Medical Center.

4.2.3 Antibodies
Details of the antibodies used in this work are described in Table 4.1.
Table 4.1. Antibody Information Table
Protein Target

Species

Company

Catalog #

Assay

Conditions

Acetylated Histone 3 (K56)

rabbit

Millipore

04-1135

IF, IHC-F

Histone H2AX

rabbit

Cell Signaling

#7631

IF, WB

1:250, 1:100
1:150, 1:2000
in BSA

Histone H3

rabbit

Cell Signaling

#4499

IF

1:250

phospho-H2AX (Y142)

rabbit

Abcam

ab9045

IF, WB

1:200, 1:2000

Sox2

rabbit

Abcam

ab7959

IHC-F

1:100

Sox2

mouse

Abcam

ab79351

IF, IHC-F

γH2AX (S139)

mouse

Millipore

05-636

WB, IHC-F

1:200, 1:100
1:4000 in
BSA, 1:400

γH2AX (S139)

rabbit

Cell Signaling

#7631

IHC-F

1:150

99

p300

rabbit

Santa Cruz

WB

GAPDH
FITC-conjugated antirabbit
FITC-conjugated antimouse
AMCA-conjugated antimouse
AMCA-conjugated antirabbit
Texas Red-conjugated
anti-mouse
Texas Red-conjugated
anti-rabbit
HRP-conjugated antimouse
HRP-conjugated antirabbit

mouse

Sigma Aldrich

G8795

WB

1:4000 in milk
1:100,000 in
milk

donkey

Vector

FI-1000

IF, IHC-F

1:100

horse

Vector

FI-2000

IF, IHC-F

1:100

horse

Vector

CI-2000

IF

1:75

donkey

Vector

CI-1000

IF

1:75

horse

Vector

TI-2000

IF, IHC-F

1:100

donkey

Vector

TI-1000

IF, IHC-F

1:100

rabbit

Sigma Aldrich

A9044

WB

1:5000 in milk

goat

Sigma Aldrich

A0545

WB

1:5000 in milk

4.2.4 X-Ray Irradiation and Tissue Sectioning:
Cells and animals were irradiated in the RS-2000 Biological Research Irradiator (Rad-Source) at
room temperature, with mock/control irradiated samples brought into the room to simulate the
reduction in ambient temperature and account for any stress imparted by the travel. Cells were
always placed within the central circle directly under the x-ray source to maintain consistency in
dose between samples. Animals were anesthetized with isofluorane and placed on their back in
the machine for whole-body irradiation to properly expose all tissues of interest to the x-ray
source. Accuracy of all doses was confirmed by dosimeter probe. Both cells and animals were
randomly assigned to individual timepoints or sham-irradiation controls.

Following irradiation, mice were sacrificed at specific timepoints by CO 2 asphyxiation and cervical
dislocation. Organs were harvested, placed in OCT media and frozen in liquid nitrogen. Frozen
tissues were sectioned on a cryostat machine at a thickness of 10μm, placed onto adhesive
o

slides and stored at -80 C.
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4.2.5 Western Blotting:
Cellular protein lysates were collected in RIPA buffer, electrophoresed on 4-15% Tris-Glycine
o

polyacrylamide gels (BioRad), transferred onto PVDF membranes and incubated overnight at 4 C
with various primary antibodies followed by washing and secondary antibody incubation for 2hr at
room temperature. Super ECL (GE/Pierce) was used as substrate for detection on
autoradiography film or ChemiDoc MP digital system (BioRad).

4.2.6 Immunofluorescence:
Freshly frozen tissues were isolated from testis, brain, intestine and skin following 6Gy irradiation
or 0Gy mock before embedding in OCT media and sectioning onto slides. Slides of tissue
sections or coverslips of cells were fixed in 4% formaldehyde and permeabolized with 0.2%
Triton-X followed by blocking with 2% BSA. Tissues were incubated with primary antibodies in 1%
o

BSA at 37 C for 3hr, washed and then incubated with secondary fluorescently-tagged secondary
o

antibodies for 45min at 37 C. Tissues were then mounted in place with coverslips containing
mounting media with DAPI (Vector) for identification of nuclei.

Cells were similarly fixed in 4% formaldehyde and permeabilized with 0.2% Triton-X before
o

blocking. For double-color staining, primary antibodies were incubated together for 1hr at 37 C
followed by wash and incubation with fluorescently-tagged secondary antibodies for 30min at
o

37 C. For triple-color staining, following the original staining procedure, cells were incubated with
o

o

1:1000 α-γH2AX antibody for 15min at 37 C followed by 12min incubation at 37 C with the
appropriate secondary antibody. Anti γH2AX antibody was chosen to match Sox2 to avoid crossreaction with the other target antigen of interest.

4.2.7 p300 siRNA Transfection and Molecular Inhibition
For each sample. 563nM mouse EP300 or non-targeting control siGENOME SMARTpool siRNA
(Dharmacon) was incubated together with 3.75% RNAiMAX lipofectamine transfection reagent
(Invitrogen) in Opti-MEM media (Invitrogen) for 5min. siRNA complex was added to cells and
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incubated in media without any antibiotic for 16h prior to irradiation, at a final concentration of
51.2nM siRNA. For pharmacological inhibition of H3K56ac, bromodomain inhibitor I-CBP112
(Cayman Chemical) was incubated with cells at a final concentration of 5µM prior to irradiation
and washed from cells 30min later (unless cells were harvested earlier).

4.2.8 Neutral Comet Assay:
To assess repair of DNA double strand breaks, neutral comet assays were performed using
CometSlide assay kits (Trevigen). Cells were collected at multiple timepoints following 6 Gy
irradiation or 0 Gy mock and embedded in agarose on slides at equal concentrations. Slides were
electrophoresed in TAE buffer, fluorescently stained with SYBR Green (Trevigen), and visualized
by fluorescent microscopy. Olive comet moment was calculated using the CometScore software
(TriTek) to analyze 50-100 comets per sample, with each series of timepoints repeated at least
three independent times as both biological and technical replicates. Individual comets were
randomly selected for scoring from similar regions of the slide in all samples. Outliers were
eliminated that fell greater than 1.5 standard deviations from the mean. Standard error was
calculated for each cell type and timepoint normalized to the value of the 0min samples, while the
significance of the difference between cell types over time was analyzed by Analysis of
Covariance (ANCOVA) using XLStat statistical software (Addinsoft), with two-sided significance
set at p<0.05. Data from all samples was approximately normally distributed, and the standard
deviation between samples within the same experiment was similar. Samples were excluded
from analysis only due to technical errors from the assay or cells being visibly unhealthy.

4.2.9 Laser Microirradiation
Stem cells (ES, NS) were co-plated with non-stem cells (ED, MEF) on glass coverslips and
incubated for 2 days with 30μM BrdU (Sigma Aldrich) to sensitize DNA for DSB induction. Prior
to laser microirradiation, cells were incubated with Stem Cell cDy1 Dye (Active Motif) for 30min to
fluorescently label live stem cells for identification. Coverslips were then placed in circular
magnetic chambers (Quorum Technologies) with media to be properly aligned for
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microirradiation. Cells were microirradiated in a defined narrow region across adjacent stem and
non-stem cells with 8000-12000 iterations of 405+633nm laser on the LSM 510 Confocal
Microscope (Zeiss) at 45% power output. Care was taken to include stem (cDy1 positive) as well
as non-stem cells in the DNA damage tracks. Cells were microirradiated for 20-30min per sample
unless otherwise stated, with 6-12 regions of microirradiation per sample.

3.2.10 Microscopy and Image Processing
Micrographs were captured utilizing MetaSystems ISIS imaging software on Zeiss Axioplan2
microscope or ZEN software on Zeiss LSM510 confocal microscope with the 20x, 63x or 100x
objective lenses. Minimal threshold and contrast manipulation was performed equally across
entire images. Controls were processed equally with treated samples. Adobe Photoshop CS3
software was utilized for composing the collages of multiple pictures and labeling micrographs
and Immunoblots in individual layers.

3.2.11 Statistical Analysis
A ‘two-tailed’ Student's t-test was used to calculate the statistical significance of the observed
differences. In all cases, differences were considered statistically significant when p<0.05.
Unless otherwise indicated, values represent mean ± SEM.

4.3 INTRODUCTION
Chromosomal DNA is tightly wrapped around histone proteins to package and organize DNA into
chromatin. Because DNA is so tightly bound by histones, their presence controls DNA access for
1

biological processes such as DNA replication, gene transcription and DNA repair . Histone modifications
are often generalized into broad roles, promoting either the loosening or tightening of chromatin in order
to encourage or repress nucleoprotein binding. Acetylation of lysine residues generally loosens chromatin
by neutralizing the ionic charge between DNA and histones, while lysine methylations can be either
activating or repressive depending on the specific residue. In addition to their broad cumulative effects on
chromatin density, individual histone modifications have their own specific functions. Specific histone
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modifications can serve as binding sites for recruiting proteins to DNA and controlling chromatin
organization, depending on the geographical context of the residue. This series of specific functional
2

modifications is known as the “histone code” .

In addition to controlling DNA replication and gene transcription, many of these histone modifications are
3,4

extremely important for a functioning DNA Damage Response (DDR) and effective DNA repair . Histone
modifications are involved in every step of the DDR, from chromatin opening to signaling and restoration
of the basal state. While numerous histone modifications have been implicated in a broad range of DDR
5

processes , much is still unknown about the complexity of chromatin dynamics in response to DNA
damage and during DNA repair. Additionally, all that is known about the epigenetics of the DDR comes
from studies on cancer cells or transformed differentiated cells. To our knowledge there have not been
any studies performed investigating the influence of particular histone modifications on the cellular
response to DNA damage in stem cells. Stem cell pluripotency is regulated by unique chromatin
organization along with distinctive expression of various histone modifications

6–9

. It is very likely that these

same epigenetic marks which dictate gene expression also influence DNA access for repair factors and
DDR signaling components.

We established in previous chapters that normal stem cells exhibit a severely attenuated DDR resulting in
insufficient DNA repair and promoting ionizing radiation (IR)-induced apoptosis. Here we examine the
association between these radiation responses and unique epigenetic regulation. H2AX Y142
phosphorylation status has been shown to influence cellular DNA damage sensitivity and the DDR

10–12

,

and we demonstrate that failure to dephosphorylate H2AX Y142 around break sites in stem cells is
strongly related to their radiosensitive phenotype. Moreover, the diminished DDR in stem cells is also
associated with enhanced constitutive acetylation of histone 3 lysine 56 (H3K56ac), an epigenetic mark
that may hinder the binding and retention of repair factors around double-strand breaks (DSBs)

13,14

.

Reduction of H3K56ac through knockdown and inhibition of the acetyltransferase p300 protected stem
cells from IR-induced apoptosis and restored DDR signaling. Our findings therefore indicate that stem
cells exhibit an attenuated DDR through a unique regulation of chromatin structure. We deduce that
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pluralistic epigenetic mechanisms act in concert to impede the DDR in normal stem cells, thus promoting
their radiosensitivity.

4.4 RESULTS
4.4.1 DDR attenuation in stem cells is associated with a failure to dephosphorylate H2AX
Y142 following DNA damage
Tyrosine 142 (Y142) of histone H2AX is constitutively maintained in a phosphorylated state in
chromatin, but dephosphorylation of H2AX-pY142 upon DNA damage has been determined to be
required for recruitment of mediator of DNA damage checkpoint protein 1 (MDC1) to nearby
H2AX-pS139 (γH2AX) and subsequent downstream DDR signaling

10,15

. In the absence of Y142

dephosphorylation, DDR signaling is blocked while apoptotic signaling is activated through
14

binding of JNK . We therefore investigated if the selective activation of apoptosis coincident with
an attenuated DDR in stem cells could be explained by unique regulation of H2AX Y142
phosphorylation. The presence of H2AX-pY142 was found mutually exclusive from γH2AXlabeled microirradiation tracks of DNA damage in differentiated non-stem cells, while Y142
remained prominently phosphorylated in stem cells where γH2AX was abrogated (Fig. 4.1 A-B).
Immunoblotting also confirmed that Y142 is dephosphorylated at the break sites only in non-stem
cells following IR (Fig. 4.2) MDC1 was also found not to be recruited to the tracks of DNA
damage in stem cells (Fig. 4.3A) and H2AX-pY142 was absent from MDC1-labeled tracks only in
non-stem cells (Fig. 4.3B). These data surmise that stem cells are primed to apoptose in lieu of
DNA repair signaling by the maintenance of constitutive H2AX Y142 phosphorylation following
DNA damage.
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Figure 4.1. H2AX-pY142 persists along DSBs only in cultured stem cells. Immunofluorescence costaining of Sox2 (blue) H2AX-pY142 (green), and γH2AX (red) on co-plated ES and ED cells following
microirradiation. (A)White arrowheads indicate H2AX-pY142 dephosphorylation at γH2AX-labeled DNA
breaks only in non-stem cells. (B)Arrowhead marks the path of microirradiation across the stem cell.
Individual ES and ED pictures shown were irradiated together following co-plating. White scale bars, 10μm.

Figure 4.2. Global H2AX-pY142 is reduced following irradiation only in non-stem cells. Western
blots for phosphorylated H2AX-pY142 at 15min following mock or 6Gy irradiation of ES and ED cells.
GAPDH served as a loading control.
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Figure 4.3 MDC1 is not recruited to DSBs in cultured stem cells. Immunofluorescence co-staining of
(A) Sox2 (green) and MDC1 (red) or (B) Sox2 (green), MDC1 (red), and H2AX-pY142 (blue) on co-plated
ES and ED cells following microirradiation. Individual ES and ED pictures shown were irradiated together
following co-plating. White scale bars, 10μm.

4.4.2 The absence of IRIFs inversely correlates with high H3K56ac levels in stem cells
3

Chromatin structure has been shown to have a major influence on DNA repair . Our screening for
histone modifications implicated in DDR using blastocyst stage embryos and isogenic stem/ nonstem cells, identified histone H3 lysine 56 acetylation as a potential epigenetic regulator of stem
cell radiation response. H3K56ac has been implicated as a DNA damage-responsive histone
modification

13,14,16–18

, is known to be directly involved in maintaining the pluripotent state of

embryonic stem cells

7,19

17

, and is elevated in undifferentiated cells . We therefore investigated

whether enhanced H3K56ac levels in stem cells may be related to the observed attenuation DDR
signaling. We elucidated that H3K56ac levels were dramatically enhanced within the inner cell
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mass of embryos where stem cells are located (Fig. 4.4 A), and high H3K56ac levels in cultured
ES cells sharply decreased upon differentiation (Fig. 4.4 B). Interestingly, high H3K56ac levels
were associated with an absence of γH2AX foci following irradiation of culture cells (Fig. 4.5).
This phenomenon was also observed in vivo, where high H3K56ac levels in stem cells
corresponded to strongly abrogated DDR signals (Fig. 4.6).

Figure 4.4. H3K56ac is enhanced in ES cells compared to differentiated progeny.
(A) Immunofluorescence staining for H3K56ac (red) or total histone H3 (green) on
unirradiated E4.5 day mouse embryos. (B) Immunofluorescence co-staining of Sox2 (green)
and H3K56ac (red) on an unirradiated, partially differentiated ES cell colony. DAPI=DNA.
White scale bars, 10μm.
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Figure 4.5. Elevated H3K56ac levels in culture cells correlates with attenuated γH2AX
induction. Immunofluorescence co-staining of γH2AX (green) and H3K56ac (red) on co-plated
ES and ED cells 15min following 2Gy IR. DAPI=DNA. White scale bars, 10μm.

Figure 4.6. Elevated H3K56ac levels in stem cell regions correlates with attenuated γH2AX
induction. Immunofluorescence co-staining of H3K56ac (red) and γH2AX (green) in tissue niches 15min
following 6Gy IR. DAPI=DNA. Arrowheads indicate cells expressing high H3K56ac and an absence of
γH2AX foci. White scale bars, 10μm.
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4.4.3 Stem cells lack transient reduction of H3K56ac in chromatin around DSB sites
We utilized microirradiation tracks to investigate any differential kinetics of H3K56ac changes
around DNA break sites in stem and non-stem cells at different timepoints after induction of DNA
damage. Our results revealed that acetylation of H3K56ac was significantly reduced along the
γH2AX tracks within minutes of DNA damage only in non-stem cells, while in stem cells
attenuated γH2AX corresponded with constitutively elevated H3K56ac levels that did not
substantially change in the region of DNA damage (Fig. 4.7 A-B). H3K56ac reduction was due to
decreased acetylation and not eviction of histones from the break site, as histone H3 levels did
not change along the track of DNA damage (Fig. 4.8). This reduction in H3K56ac at break sites in
non-stem cells that display robust DDR signaling was found to be transient in nature. No
alteration was observed in either stem or non-stem cells at 30min or 1h following microirradiation
(Fig. 4.9 A-B), indicating that alteration of chromatin structure may only be necessary for initial
induction and maintenance of the DDR immediately following DNA damage. Constitutively
enhanced H3K56ac in stem cells without any reduction at break sites is therefore associated with
hampered recruitment/ retention of DDR factors to DNA breaks.
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Figure 4.7. H3K56ac is reduced in non-stem but not stem cells along DSBs.
(A) Immunofluorescence co-staining of Sox2 (green), γH2AX (red) and H3K56ac (blue) on co-plated ES
and ED cells 10min following microirradiation. Arrowhead marks the path of laser microirradiation across
the stem cell. (B) Signal intensity profiles of microirradiated ES and ED cells demonstrate the
relationship between H3K56ac (blue) and yH2AX (red) across the break site. Red lines across the nuclei
indicate the path of signal intensity measurements. Sox2=green. Individual ES and ED pictures shown
were irradiated together following co-plating. White scale bars, 10μm.
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Figure 4.8. Histones are not evicted from chromatin along DSBs in stem or non-stem cells.
Immunofluorescence co-staining of Sox2 (green), γH2AX (red) and histone H3 (blue) on co-plated ES
and ED cells 10min following microirradiation. Individual ES and ED pictures shown were irradiated
together following co-plating. White scale bars, 10μm.
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Figure 4.9. Baseline H3K56ac levels are restored along DSBs in non-stem cells within 30min of
microirradiation. Immunofluorescence co-staining of Sox2 (green), γH2AX (red) and H3K56ac (blue)
on co-plated ES and ED cells (A) 30min or (B) 1h following microirradiation. Individual ES and ED
pictures shown were irradiated together following co-plating. White scale bars, 10μm.

4.4.4 Knockdown and inhibition of p300 acetyltransferase reduces H3K56ac levels
Having established a negative correlation between H3K56ac expression and γH2AX induction,
we wanted to determine whether we could modulate H3K56ac levels in order to more directly
assess its effect on radiosensitivity and the DDR in stem cells. The H3K56ac acetyltransferase
p300 was extremely elevated in both unirradiated and irradiated stem cells in culture (Fig. 4.1011), only displaying minimal observable expression in differentiated cells. p300 expression also
parallelled elevated H3K56ac levels in mixed culture (Fig. 4.12). siRNA knockdown substantially
reduced H3K56ac levels (Fig. 4.13), although the reduction was transient likely due to
compensatory effects from other acetyltransferases. We therefore confirm that p300 is an
acetyltransferase for H3K56ac, and its knockdown provides a suitable method for H3K56ac
downregulation.
113

Figure 4.10 Expression of p300 acetyltransferase is substantially higher in stem cells as
compared to non-stem cells. Western blots for p300 at multiple timepoints following mock or 6Gy
irradiation of ES and ED cells. GAPDH served as a loading control.

Figure 4.11. Elevated p300 expression corresponds with Sox2 expression in ES colonies.
Immunofluorescence co-staining of p300 (green) and Sox2 (red) on an unirradiated, partially
differentiated ES cell colony. DAPI=DNA. White scale bars, 10μm.
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Figure 4.12. Elevated p300 expression corresponds with elevated H3K56ac in ES colonies.
Immunofluorescence co-staining of p300 (green) and H3K56ac (red) on an unirradiated, partially
differentiated ES cell colony. DAPI=DNA. White scale bars, 10μm.

Figure 4.13. siRNA knockdown of p300 transiently downregulates H3K56ac in cultured stem
cells. Western blots for p300 and H3K56ac at multiple timepoints in ES cells following 16h
incubation with negative control or p300 siRNA. GAPDH served as a loading control.
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4.4.6 Reducing H3K56ac levels imparts radioprotection on stem cells through restoration
of the DDR
Being able to downregulate H3K56ac allowed us to determine whether enhanced H3K56ac levels
are truly responsible for the abrogation of the DDR in stem cells. p300 knockdown (and
associated H3K56ac reduction) in stem cells increased global induction of γH2AX (Fig 4.14)
following irradiation. We then performed a comet assay to assess whether an enhanced DDR due
to decreased H3K56ac levels could successfully improve DNA repair proficiency. Knockdown of
p300 in stem cells resulted in significant improvement in DNA repair efficacy as indicated by a
hastened reduction in DNA breaks (Fig. 4.15). We then examined whether this improved DNA
repair through increased DDR signaling was sufficient to reduce stem cell radiosensitivity. IRinduced apoptosis was significantly reduced in stem cells following p300 knockdown (Fig. 4.16),
determining that constitutively elevated H3K56ac in stem cells is indeed a major contributor to
their IR hypersensitivity. p300 knockdown had no effect on either baseline or IR-induced cell
death in non-stem cells, indicating that H3K56ac modulation can be utilized to specifically
regulate radiosensitivity in stem cells without unintended effects on other cell types.

Figure 4.14. p300 knockdown increases γH2AX induction in cultured stem cells following
irradiation. Western blot for γH2AX at 15min following either sham or 6Gy IR of ES cells after 16h
incubation with negative control or p300 siRNA. GAPDH served as a loading control.
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Figure 4.15. p300 knockdown improves DNA repair in cultured stem cells. Olive moments of NS
and ND cell comet assay tails were quantified at different timepoints following sham or 6Gy IR after 16h
incubation with negative control or p300 siRNA. Olive moments were normalized to the irradiated 0min
timepoint in order to measure DNA repair over time. N=3. Error bars indicate SEM.

Figure 4.16. p300 knockdown reduces IR-induced apoptosis in stem cells without any effect
on non-stem cells. Flow cytometric analysis of apoptosis comparing ES and ED cells by Annexin-V
labeling 16h following sham or 6Gy IR after 16h incubation with negative control or p300 siRNA. N=3;
** = p < 0.01; Error bars indicate SEM.
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4.5 DISCUSSION
Our work from previous chapters showed that despite being able to sense DSBs through the Mre11Nbs1-Rad50 (MRN) complex, downstream DDR signaling is abrogated in stem cells. Since stem cells are
able to sense broken DNA, they must have some inhibitory mechanism(s) blocking DDR factors from
accessing/ accumulating around DSBs. Our data suggests that the failure of stem cells to
dephosphorylate H2AX-pY142 following DNA damage blocks DDR signaling and instead induces
apoptosis through c-Jun N-terminal kinase (JNK). This epigenetic mechanism explains how stem cells
can undergo IR-induced apoptosis without active DDR signaling (Supplementary Fig. 4b). In addition to
providing novel evidence that unique regulation of H2AX Y142 phosphorylation status in stem cells may
regulate their radiosensitivity, this study also suggests that H2AX-pY142 may directly inhibit S139 γH2AX
phosphorylation. While it is unclear whether H2AX-pY142 is directly blocking the initial phosphorylation of
H2AX-S139 in stem cells or if Y142 phosphorylation merely prevents MDC1-mediated amplification of
γH2AX

20

along the break site; regulation of H2AX-pY142 appears to influence cellular responses to DNA

damage. We propose that the close proximity of H2AX-pY142 sterically hinders access to the H2AX-S139
site, therefore blocking γH2AX phosphorylation and/or MDC1 binding.

H2AX-pY142 is also related to the apoptotic induction of mammalian sterile 20–like kinase-1 (MST1) and
pan-nuclear H2AX-pS139. MST1 is required for imatinib-mediated apoptosis through H2AX-pY142

21

(likely involving pJNK). Additionally, apoptotic H2AX-pS139 has been directly linked to both MDC1
inhibition

22

and enhanced Y142 phosphorylation

21

. Our work suggests that H2AX-pY142 may directly

inhibit γH2AX at S139, although it is unclear whether H2AX-pY142 is directly blocking the initial
phosphorylation of H2AX-S139 in stem cells or merely preventing MDC1-mediated amplification of γH2AX
along the break site. We propose that the close proximity of H2AX-pY142 sterically hinders access to the
S139 site, therefore blocking γH2AX induction and/or MDC1 binding. This mechanism explains how DDR
signaling is inhibited in stem cells despite proper sensing of DSBs.

We also elucidated that continuously elevated H3K56ac in stem cells is associated with abrogated
induction of the DDR following DNA damage. Existing literature has primarily only assessed global
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changes in H3K56ac, with contradictory results concerning whether levels increase
13,14,23

16,17

or decrease

following genotoxic stress. In one of the few studies that assessed local H3K56ac changes around

break sites, however, Miller et al. demonstrated that H3K56ac is absent from γH2AX within
14

microirradiated regions of DNA damage in cancer cells , providing rationale to investigate whether
enhanced levels of H3K56ac in stem cells are mechanistically associated with an abrogated DDR. These
inconsistencies may result from the dynamic nature of the H3K56ac radioresponse

14,24

, and our results

confirm that DNA damage-induced depletion of H3K56ac occurs only transiently during the early stages
25

of DDR signaling. H3K56ac is required for chromatin reassembly at the end of DSB repair in yeast ,
however this may merely explain why H3K56ac levels are so quickly restored to baseline following
transient reduction. Histone deacetylation at specific sites may also be the mechanism responsible for the
transient compaction of chromatin locally surrounding DSBs that has been found to be important for
26

proper DDR signaling . The temporal response of H3K56ac to DNA damage suggests dynamic interplay
of associated histone deacetylases and acetyltransferases around DNA break sites. While histone
acetylation is generally associated with the overall loosening of chromatin, acetylation at specific residues
such as H3K56 may create a non-permissive chromatin environment for DNA repair, either blocking
access for recruitment of repair factors or allowing binding of repressor proteins that could restrict IRIF
maturation.

While several acetyltransferases
H3K56ac levels

13,16,17

and deacetylases

14,17,18,27

have been shown to effect mammalian

13,16,17

, we chose to target p300 acetyltransferase for modulation of H3K56ac levels. p300

has been implicated in H3K56ac regulation by many studies and mirrors H3K56ac recruitment to ESspecific genes

7,19,28

. In addition to its role as an acetyltransferase, p300 and the related CREB-binding

protein (CBP) also act as transcriptional coactivators by directing assembly of transcriptional machinery at
promoter regions

29,30

. p300 and CBP also play a role in the induction of apoptosis, primarily through their

regulation of p53. p300 binding to p53 may promote its degradation under basal conditions, but upon
cellular stress p300/CBP acetylation of p53 promotes p53 transcriptional activation of target genes
Additionally, p300 and CBP are also mutated in many cancers
36

35

29,31–34

and p300 (but not CBP) loss has been

shown to impair apoptosis in culture cells . It is therefore plausible that p300 knockdown could reduce
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.

radiosensitivity independent of H3K56ac. Several lines of evidence suggest that reduced p53 activation
is not responsible for improved radioresponses in stem cells following p300 knockdown, however. Neither
p53

37

or its upstream kinase ataxia telangiectasia mutated (ATM) (Fig. 3.19) is required for DNA

damage-induced apoptosis in stem cells. Additionally, p300 knockdown only affected radiosensitivity in
stem cells where enhanced H3K56ac levels are the most predominant p300-related phenotype. These
data suggests that there may be a threshold level of H3K56ac expression during DDR signaling above
which the recruitment of repair factors is inhibited. H3K56ac reduction therefore has no effect in
differentiated cells with basally low levels of H3K56ac and the ability to downregulate H3K56ac along
DSBs, however it has a substantial effect on the radiation responses of stem cells. Based on the large
difference in p300 expression between stem and non-stem cells, it is also possible that H3K56ac
regulation in stem cells is more p300-dependent than other cell types, and therefore p300 knockdown
only has a significant effect on stem cells. Either way, these possibilities postulate that H3K56ac
modulation may be used to specifically radioprotect stem cells without any effect on differentiated or
cancer stem cells.

Successful restoration of DDR signaling and the associated reduction in IR-induced apoptosis in stem
cells following H3K56ac downregulation indicates that elevated H3K56ac directly contributes to stem cell
radiosensitivity by preventing proper recruitment and retention of DDR factors. Because H3K56ac
modulation only affected the radiosensitivity of stem cells, p300 and other H3K6ac regulators may serve
as useful pharmacological targets for preventing stem cell dropout during radiation therapy. Protecting
stem cells will minimize clinical consequences of radiation therapy and allow the use of higher doses for
more effective cancer treatment.
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CHAPTER 5
Conclusions and Ongoing Work
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5.1 SUMMARY
Radiation therapy utilizes targeted ionizing radiation (IR) to induce double-strand breaks (DSBs) in cancer
cells, leading to destruction of the tumor. While every effort is made to spare normal tissue, nevertheless
patients often experience detrimental clinical consequences following radiation therapy as a result of
damaged normal tissue. There are several mechanisms of long-term radiation injury; this project focused
on the loss of regenerative capacity in proliferative tissues resulting in functional sequelae following
normal tissue turnover. Due to the loss of regenerative capacity and observable damage to the stem cell
compartment, this form of radiation injury has been attributed to stem cell dropout. Despite this
association, conflicting evidence exists concerning the true radiosensitivity of stem cells themselves
compared to surrounding differentiated cells within their respective tissue niche. Previous studies have
only investigated specific stem cell compartments or individual cell culture models. Stem cell culture
models typically involve high-passage, established cell lines and do not compare stem cells with their
directly differentiated isogenic progeny. In order to identify conserved molecular mechanisms underlying
stem cell radiation responses, we investigated stem cell radiosensitivity in four clinically relevant stem cell
niches as well as two primary, early passage culture models from mice. In vivo stem cell compartments
assayed in this project included the subventricular zone within the dentate gyrus of brain, the
seminiferous tubules of testis, the hair follicle in skin and intestinal crypts. For culture models, embryonic
stem (ES) cells were isolated from the inner cell mass of blastocyst-stage embryos and neural stem (NS)
cells were freshly dissected from the hippocampus of P0-P2 mouse pups. Both culture models were
directly differentiated by removal of growth factors from media and assayed in parallel with their
differentiated progeny.

Whole-body irradiation of mice induced apoptosis exclusively within individually labeled stem cells of all
four tissue niches and this differential radiosensitivity was recapitulated in both culture models. Dose
curves determined that stem cells are radiosensitive at as low as 2Gy while differentiated cells only begin
to apoptose above 8Gy. While the long-held tenet of radiobiology known as the Law of Bergonié and
Tribondeau states that radiosensitivity is directly related to proliferation rate, we found no association
between proliferation status and radiosensitivity among our stem cell models. While radiosensitivity
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differences among differentiated cell populations correlated with proliferation status, enhanced
radiosensitivity in stem cells was not associated with enhanced proliferation. Radiation responses did
differ between stem and non-stem cells across the cell cycle however, as stem cells apoptosed much
more broadly across the cell cycle. Stem cells are therefore hypersensitive to IR independent of their
proliferation status, in contrast with their radioresistant differentiated progeny.

Investigation of DDR signaling among stem and differentiated cells elucidated that stem cells both in vivo
and in culture exhibit a strongly attenuated DDR as indicated by substantially reduced induction of γH2AX
as well as reduced activation and recruitment of phosphorylated ATM. Muted DDR signaling in stem cells
was associated with inadequate DNA repair and improper cell cycle checkpoint arrest. Despite the
absence of γH2AX foci, at late timepoints stem cells exhibited apoptotic pan-nuclear H2AX
phosphorylation at the same S139 as part of the MST1-JNK-H2AX pathway. Diminished DDR signaling in
stem cells is therefore associated with their radiosensitivity.

Stem cells also showed a unique persistence of H2AX Y142 around break sites, resulting in hindered
recruitment of the DDR factor MDC1 and instead prompting JNK-mediated apoptosis. Failure to
dephosphorylate H2AX Y142 may thus direct stem cells toward apoptosis in lieu of DNA repair. Histone
3 lysine 56 acetylation (H3K56ac) was found to be elevated in stem cells and was inversely correlated
with robust induction of γH2AX foci both in vivo and in culture. H3K56ac was reduced along break sites in
differentiated but not stem cells, and H3K56ac downregulation reduced IR-induced apoptosis in stem
cells through restoration of the DDR. Unique epigenetic regulation can thereby promote heterogeneous
radiation responses among different cell types. Therapeutic modulation of these histone modifications
may protect stem cells from IR and thus allow more efficient treatment of cancer patients.

5.2 ONGOING WORK AND FUTURE DIRECTIONS
5.2.1 H3K56ac
We are continuing to investigate the contribution of H3K56ac toward stem cell radiosensitivity.
Preliminary evidence suggests that the presence of elevated H3K56ac and its persistence along
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DSBs is hindering DDR signaling. It is unclear at which step H3K56ac might be interrupting DDR
progression. H3K56ac may prevent initial ATM kinase recruitment to DSBs, blocking its activation
and phosphorylation of H2AX at S139. H3K56ac may also be acting through its effect on H2AXpY142, blocking recruitment of EYA phosphatase which is responsible for H2AX Y142
1

phosphorylation . H3K56ac could even itself be inhibiting expansion of γH2AX around the DSB
and thereby blocking DDR amplification. A whole series of experiments will be required to parse
apart the specific locations in the pathway at which H3K56ac is acting.

5.2.1.1 Targeting ASF1 and the p300/CBP bromodomain
Current experiments are focusing on alternative methods for reducing H3K56ac levels
aside from p300 knockdown. In addition to its acetyltransferase activity, p300 also
2

functions as a transcriptional co-activator , so it would be useful to parse apart these
functions. The bromodomain of p300 and its sister protein CBP binds acetylated lysines
on target proteins

3,4

and is necessary for efficient acetylation of these proteins as well.

While p300/CBP can promote aggregation of transcription factors at promoter regions
2

through a distinct activation domain , its transcriptional coactivation function is often
3

acetylation-dependent for proteins such as p53 . Acetylation of H3K56 may possibly be
more precisely targeted by modulation of the interaction with ASF1, a histone chaperone
that promotes p300/CBP mediated acetylation of H3K56

5–8

. ASF1 mutually interacts with

the bromodomain and H3K56ac to conformationally promote histone acetylation. While
the bromodomain can bind various acetylated lysines, CBP bromodomain binding has
been found to most strongly interact with H3K56ac. Additionally, ASF1 specifically
promotes acetylation of H3K56ac. We have therefore begun experiments utilizing ICBP112, a p300/CBP-specific bromodomain inhibitor that has been shown to selectively
reduce H3K56ac, potentially acting through disruption of the ASF1-bromodomain-H3K56
interaction. In addition to potentially improving specificity towards H3K56ac,
pharmacological inhibition will also allow more precise temporal control of H3K56ac
modulation. Genetic knockdowns of ASF1 may also produce H3K56ac-specific
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downregulation, although this may prove less effective for improving repair as ASF1mediated H3K56ac is required for DDR recovery through γH2AX dephosphorylation and
6,9

basal chromatin reassembly .

5.2.1.2 H3K56ac upregulation and targeted chromatin modulation
In parallel with downregulation of H3K56ac in stem cells, we would like to investigate
whether upregulation of H3K56ac can impart enhanced radiosensitivity to differentiated
cells. This could be performed through overexpression of p300 by plasmid transfection,
pharmacological molecular activators, or newly-developed CRISPR-based transcriptional
activation (Santa Cruz). Similarly, knockout and inhibition of various histone deacetylases
could be used, although multiple deacetylases have been shown to act on
H3K56ac

7,8,10,11

and they are unlikely to exhibit much specificity. Reversing the

radiosensitivity phenotype in both directions would thoroughly confirm the hypothesis and
provide insights into both radioprotection and radiosensitization. H3K56ac and its
relationship to the DDR is likely complicated however, and simple upregulation may not
be sufficient to modify radiation responses. Additionally, the dynamic influence of the
various acetyltransferases and deacetylases on H3K56ac may differ among stem and
differentiated cells. Nonetheless, attempting H3K56ac upregulation in differentiated cells
will be a worthwhile experiment.

A major issue with existing epigenetics research is the difficulty of modulating chromatin
at designated sites. Knockdown or inhibition of an acetyltransferase or deacetylase will
affect global acetylation levels, producing pleiotropic effects that may be hard to directly
attribute to changes specifically at the break site. New technologies however enable
tethering and recruitment of chromatin modifying enzymes to DNA DSBs. The Misteli Lab
has developed an effective system utilizing I-Sce1 endonuclease recognition sites
bordered by LacO/TetO sequences. Integrated I-Sce-I will only cut at the inserted
recognition site to produce a site-specific DSB, and chromatin modifiers can be tethered
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to additionally transfected LacR/TetR repressor which will recruit them to the DSB at the
LacO/TetO sites

12,13

. A similar procedure can be performed using CRISPR technology
14

with catalytically-inactive Cas9 endonuclease . These methods could allow more precise
analysis of H3K56ac effects specific to the region around DSBs.

5.2.2 Cancer Stem Cells
Cancer stem cells (CSCs) are a unique cell type that while still debated are generally believed to
exist at the core of many tumors. Similar to normal stem cells, cancer stem cells are capable of
regenerating all other cells of a tumor and therefore must be destroyed in order to prevent
15

recurrence . It is unclear whether cancer stem cells originate from the de-differentiation of
radioresistant differentiated cells or the transformation of normal stem cells, but either way the
majority of evidence suggests that they are extremely radioresistant

15–17

yet exhibit an

undifferentiated stem cell-like phenotype. Several factors contribute to impart complex and often
unique concerted mechanisms of radioresistance in CSCs

15–20

, and it would be extremely

interesting to compare their radiation responses to those in normal stem and differentiated cells.
17

While an elevated DDR has been implicated in cancer stem cell radioresistance , a failure to
21

induce γH2AX has been shown in breast CSCs . Parallel comparison of the IR-responsive
mechanisms and epigenetic regulation examined in this project among stem, differentiated, and
cancer stem cells would provide additional context for the uniqueness of stem cell radiation
responses and how to best target radioprotective therapies.
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